{
"company_details": [
{
"company_id": "0000895930",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2010/feature_distribution/feature_distribution_0000895930.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2010/graphs/IME_0000895930.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000000000.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000000000_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2010/plot_over_time/0000895930_main_keyfigs.svg",
"name": "Amsurg CORP",
"rank": 1,
"regression_plot": "No stock price available",
"report_text": "The relative strengths and weaknesses of Amsurg CORP are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Amsurg CORP compared to the market average is the variable Stockholders Equity, increasing the Economic Capital Ratio by 103% points.The greatest weakness of Amsurg CORP is the variable Other Revenues, reducing the Economic Capital Ratio by 42% points.
The company's Economic Capital Ratio, given in the ranking table, is 295%, being 105% points above the market average of 191%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2010/report/0000895930_2011_Amsurg_CORP.pdf",
"shrinked_graph_json": {
"2010": {
"Assets": "2.73",
"Stockholders Equity": "103",
"ECR before LimitedLiability": "103",
"Intangible Assets": "7.64",
"Other Liabilities": "22.2",
"Liabilities": "89.9",
"Liabilities, Current": "26.2",
"Long Term Liabilities": "60.7",
"Other Expenses": "15.2",
"Expenses": "7.92",
"Revenues": "-42.0",
"Net Income": "12.6",
"Cost of Goods and Services Sold": "13.6",
"General and Administrative Expense": "6.31",
"Labor Expense": "-18.3",
"Operating Costs and Expenses": "-8.44",
"Other Revenues": "-42.0",
"Comprehensive Net Income": "-3.07",
"Other Net Income": "42.3",
"Other Compr. Net Income": "-16.2",
"Economic Capital Ratio": "105"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2010/plot_over_time/0000895930_strength_weakness.svg",
"table_records": {
"2010": {
"input_variables": {
"Assets, Current": "132,956",
"Assets, Non-Current": "0",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "24,910",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "905,858",
"Labor Expense": "213,274",
"Liabilities, Current": "43,563",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "148,878",
"Other Assets": "7,897",
"Other Compr. Net Income": "-129,337",
"Other Expenses": "141,759",
"Other Liabilities": "0",
"Other Net Income": "709,317",
"Other Revenues": "0",
"Property Plant and Equipment": "119,167",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "1,165,878",
"Liabilities": "43,563",
"Expenses": "528,821",
"Revenues": "0",
"Stockholders Equity": "1,122,315",
"Net Income": "180,496",
"Comprehensive Net Income": "51,159",
"BaseVar": "1,288,458",
"ECR before LimitedLiability": "278%",
"Economic Capital Ratio": "295%"
}
}
},
"top_rated": true,
"trend": null,
"value": 2.9516424899857046,
"company_index": "https://www.realrate-archive.com/us_health_services/2010/industry_indexes/0000895930.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2010/analytics/equity/0000895930.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2010/analytics/profit_loss/0000895930.svg"
},
{
"company_id": "0000352915",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2010/feature_distribution/feature_distribution_0000352915.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2010/graphs/IME_0000352915.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000352915.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000352915_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2010/plot_over_time/0000352915_main_keyfigs.svg",
"name": "Universal Health Services Inc",
"rank": 2,
"regression_plot": "No stock price available",
"report_text": "The relative strengths and weaknesses of Universal Health Services Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Universal Health Services Inc compared to the market average is the variable Liabilities, increasing the Economic Capital Ratio by 72% points.The greatest weakness of Universal Health Services Inc is the variable Other Revenues, reducing the Economic Capital Ratio by 42% points.
The company's Economic Capital Ratio, given in the ranking table, is 266%, being 75% points above the market average of 191%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2010/report/0000352915_2011_Universal_Health_Services_Inc.pdf",
"shrinked_graph_json": {
"2010": {
"Assets": "3.86",
"Liabilities": "72.2",
"Stockholders Equity": "68.2",
"ECR before LimitedLiability": "73.3",
"Property Plant and Equipment": "8.34",
"Assets, Non-Current": "17.0",
"Other Assets": "-9.32",
"Other Liabilities": "20.5",
"Long Term Liabilities": "56.6",
"Other Expenses": "17.7",
"Expenses": "-16.1",
"Revenues": "-42.2",
"Net Income": "-6.14",
"Cost of Goods and Services Sold": "13.5",
"General and Administrative Expense": "6.28",
"Labor Expense": "-34.0",
"Operating Costs and Expenses": "-19.9",
"Other Revenues": "-42.2",
"Comprehensive Net Income": "-4.95",
"Other Net Income": "46.7",
"Economic Capital Ratio": "75.1"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2010/plot_over_time/0000352915_strength_weakness.svg",
"table_records": {
"2010": {
"input_variables": {
"Assets, Current": "1,331,116",
"Assets, Non-Current": "2,943,853",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "223,915",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "2,589,914",
"Labor Expense": "2,423,102",
"Liabilities, Current": "826,299",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "1,738,381",
"Other Assets": "-2,589,914",
"Other Compr. Net Income": "0",
"Other Expenses": "906,992",
"Other Liabilities": "0",
"Other Net Income": "5,568,185",
"Other Revenues": "0",
"Property Plant and Equipment": "3,252,967",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "7,527,936",
"Liabilities": "826,299",
"Expenses": "5,292,390",
"Revenues": "0",
"Stockholders Equity": "6,701,637",
"Net Income": "275,795",
"Comprehensive Net Income": "275,795",
"BaseVar": "9,607,405",
"ECR before LimitedLiability": "239%",
"Economic Capital Ratio": "266%"
}
}
},
"top_rated": true,
"trend": null,
"value": 2.6580987688873132,
"company_index": "https://www.realrate-archive.com/us_health_services/2010/industry_indexes/0000352915.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2010/analytics/equity/0000352915.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2010/analytics/profit_loss/0000352915.svg"
},
{
"company_id": "0000731012",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2010/feature_distribution/feature_distribution_0000731012.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2010/graphs/IME_0000731012.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000731012.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000731012_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2010/plot_over_time/0000731012_main_keyfigs.svg",
"name": "Healthcare Services Group Inc",
"rank": 3,
"regression_plot": "No stock price available",
"report_text": "The relative strengths and weaknesses of Healthcare Services Group Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Healthcare Services Group Inc compared to the market average is the variable Stockholders Equity, increasing the Economic Capital Ratio by 99% points.The greatest weakness of Healthcare Services Group Inc is the variable Liabilities, Current, reducing the Economic Capital Ratio by 30% points.
The company's Economic Capital Ratio, given in the ranking table, is 265%, being 74% points above the market average of 191%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2010/report/0000731012_2011_Healthcare_Services_Group_Inc.pdf",
"shrinked_graph_json": {
"2010": {
"Assets, Current": "49.9",
"Assets": "29.0",
"Liabilities": "21.3",
"Stockholders Equity": "99.0",
"ECR before LimitedLiability": "72.3",
"Other Assets": "3.90",
"Intangible Assets": "-4.32",
"Other Liabilities": "11.4",
"Liabilities, Current": "-30.1",
"Long Term Liabilities": "33.3",
"Other Expenses": "9.01",
"Expenses": "30.9",
"Revenues": "-21.9",
"Net Income": "9.88",
"Cost of Goods and Services Sold": "7.28",
"General and Administrative Expense": "3.37",
"Labor Expense": "5.40",
"Operating Costs and Expenses": "5.94",
"Other Revenues": "-21.9",
"Comprehensive Net Income": "10.5",
"Economic Capital Ratio": "74.1"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2010/plot_over_time/0000731012_strength_weakness.svg",
"table_records": {
"2010": {
"input_variables": {
"Assets, Current": "221,775",
"Assets, Non-Current": "42",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "16,955",
"Labor Expense": "0",
"Liabilities, Current": "40,531",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "32,506",
"Other Compr. Net Income": "0",
"Other Expenses": "19,678",
"Other Liabilities": "0",
"Other Net Income": "54,119",
"Other Revenues": "0",
"Property Plant and Equipment": "6,656",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "277,934",
"Liabilities": "40,531",
"Expenses": "19,678",
"Revenues": "0",
"Stockholders Equity": "237,403",
"Net Income": "34,441",
"Comprehensive Net Income": "34,441",
"BaseVar": "196,131",
"ECR before LimitedLiability": "238%",
"Economic Capital Ratio": "265%"
}
}
},
"top_rated": true,
"trend": null,
"value": 2.6476486657047444,
"company_index": "https://www.realrate-archive.com/us_health_services/2010/industry_indexes/0000731012.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2010/analytics/equity/0000731012.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2010/analytics/profit_loss/0000731012.svg"
},
{
"company_id": "0001022079",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2010/feature_distribution/feature_distribution_0001022079.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2010/graphs/IME_0001022079.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001022079.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001022079_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2010/plot_over_time/0001022079_main_keyfigs.svg",
"name": "Quest Diagnostics INC",
"rank": 4,
"regression_plot": "No stock price available",
"report_text": "The relative strengths and weaknesses of Quest Diagnostics INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Quest Diagnostics INC compared to the market average is the variable Liabilities, increasing the Economic Capital Ratio by 70% points.The greatest weakness of Quest Diagnostics INC is the variable Other Net Income, reducing the Economic Capital Ratio by 56% points.
The company's Economic Capital Ratio, given in the ranking table, is 261%, being 71% points above the market average of 191%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2010/report/0001022079_2011_Quest_Diagnostics_INC.pdf",
"shrinked_graph_json": {
"2009": {
"Assets": "10.8",
"Stockholders Equity": "79.5",
"ECR before LimitedLiability": "71.5",
"Intangible Assets": "9.50",
"Liabilities, Current": "10.4",
"Liabilities": "52.4",
"Long Term Liabilities": "42.0",
"Other Liabilities": "4.28",
"Other Expenses": "16.3",
"Expenses": "7.55",
"Revenues": "36.8",
"Net Income": "1.97",
"General and Administrative Expense": "-16.0",
"Cost of Goods and Services Sold": "-12.9",
"Labor Expense": "5.30",
"Operating Costs and Expenses": "12.5",
"Depreciation, Depletion, Amortization": "1.15",
"Other Revenues": "36.8",
"Comprehensive Net Income": "1.97",
"Other Net Income": "-47.2",
"Economic Capital Ratio": "71.9"
},
"2010": {
"Other Liabilities": "21.1",
"Liabilities": "69.8",
"Assets, Current": "-2.44",
"Stockholders Equity": "52.8",
"ECR before LimitedLiability": "69.0",
"Liabilities, Current": "-4.04",
"Long Term Liabilities": "58.1",
"Other Expenses": "27.5",
"Expenses": "-16.4",
"Cost of Goods and Services Sold": "-53.7",
"General and Administrative Expense": "-19.4",
"Labor Expense": "10.5",
"Operating Costs and Expenses": "11.5",
"Depreciation, Depletion, Amortization": "1.89",
"Other Revenues": "63.7",
"Revenues": "63.7",
"Property Plant and Equipment": "-4.82",
"Intangible Assets": "13.5",
"Economic Capital Ratio": "70.8",
"Other Compr. Net Income": "1.23",
"Other Net Income": "-56.5"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2010/plot_over_time/0001022079_strength_weakness.svg",
"table_records": {
"2009": {
"input_variables": {
"Assets, Current": "1,679,425",
"Assets, Non-Current": "150,663",
"Cost of Goods and Services Sold": "4,321,475",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "1,747,618",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "5,907,609",
"Labor Expense": "0",
"Liabilities, Current": "1,059,212",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "487,513",
"Other Liabilities": "0",
"Other Net Income": "-132,415",
"Other Revenues": "7,455,243",
"Property Plant and Equipment": "825,946",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "8,563,643",
"Liabilities": "1,059,212",
"Expenses": "6,556,606",
"Revenues": "7,455,243",
"Stockholders Equity": "7,504,431",
"Net Income": "766,222",
"Comprehensive Net Income": "766,222",
"BaseVar": "11,883,560",
"ECR before LimitedLiability": "242%",
"Economic Capital Ratio": "268%"
}
},
"2010": {
"input_variables": {
"Assets, Current": "1,605,417",
"Assets, Non-Current": "189,494",
"Cost of Goods and Services Sold": "4,317,247",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "1,707,673",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "5,898,343",
"Labor Expense": "0",
"Liabilities, Current": "1,214,268",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "474,001",
"Other Liabilities": "0",
"Other Net Income": "-112,987",
"Other Revenues": "7,368,925",
"Property Plant and Equipment": "834,376",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "8,527,630",
"Liabilities": "1,214,268",
"Expenses": "6,498,921",
"Revenues": "7,368,925",
"Stockholders Equity": "7,313,362",
"Net Income": "757,017",
"Comprehensive Net Income": "757,017",
"BaseVar": "11,861,366",
"ECR before LimitedLiability": "233%",
"Economic Capital Ratio": "261%"
}
}
},
"top_rated": true,
"trend": -3.0,
"value": 2.6143357242596568,
"company_index": "https://www.realrate-archive.com/us_health_services/2010/industry_indexes/0001022079.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2010/analytics/equity/0001022079.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2010/analytics/profit_loss/0001022079.svg"
},
{
"company_id": "0000893949",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2010/feature_distribution/feature_distribution_0000893949.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2010/graphs/IME_0000893949.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000893949.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000893949_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2010/plot_over_time/0000893949_main_keyfigs.svg",
"name": "Pediatrix Medical Group Inc",
"rank": 5,
"regression_plot": "No stock price available",
"report_text": "The relative strengths and weaknesses of Pediatrix Medical Group Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Pediatrix Medical Group Inc compared to the market average is the variable Intangible Assets, increasing the Economic Capital Ratio by 36% points.The greatest weakness of Pediatrix Medical Group Inc is the variable Other Revenues, reducing the Economic Capital Ratio by 32% points.
The company's Economic Capital Ratio, given in the ranking table, is 221%, being 31% points above the market average of 191%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2010/report/0000893949_2011_Pediatrix_Medical_Group_Inc.pdf",
"shrinked_graph_json": {
"2010": {
"Assets, Current": "-5.23",
"Assets": "6.34",
"Liabilities": "22.2",
"Stockholders Equity": "29.7",
"ECR before LimitedLiability": "28.9",
"Property Plant and Equipment": "-10.7",
"Intangible Assets": "35.6",
"Other Liabilities": "6.46",
"Liabilities, Current": "-9.19",
"Long Term Liabilities": "24.1",
"Other Revenues": "-32.1",
"Revenues": "-32.1",
"Net Income": "1.69",
"Other Expenses": "-26.8",
"Comprehensive Net Income": "2.60",
"Cost of Goods and Services Sold": "10.7",
"General and Administrative Expense": "-2.85",
"Labor Expense": "7.92",
"Operating Costs and Expenses": "8.72",
"Other Net Income": "32.9",
"Economic Capital Ratio": "30.7"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2010/plot_over_time/0000893949_strength_weakness.svg",
"table_records": {
"2010": {
"input_variables": {
"Assets, Current": "296,009",
"Assets, Non-Current": "70,151",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "154,267",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "1,601,319",
"Labor Expense": "0",
"Liabilities, Current": "320,847",
"Long Term Liabilities": "195,223",
"Operating Costs and Expenses": "0",
"Other Assets": "27,393",
"Other Compr. Net Income": "0",
"Other Expenses": "1,046,035",
"Other Liabilities": "74,122",
"Other Net Income": "1,402,993",
"Other Revenues": "0",
"Property Plant and Equipment": "42,774",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "2,037,646",
"Liabilities": "590,192",
"Expenses": "1,200,302",
"Revenues": "0",
"Stockholders Equity": "1,447,454",
"Net Income": "202,691",
"Comprehensive Net Income": "202,691",
"BaseVar": "2,615,566",
"ECR before LimitedLiability": "175%",
"Economic Capital Ratio": "221%"
}
}
},
"top_rated": false,
"trend": null,
"value": 2.2134151741058656,
"company_index": "https://www.realrate-archive.com/us_health_services/2010/industry_indexes/0000893949.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2010/analytics/equity/0000893949.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2010/analytics/profit_loss/0000893949.svg"
},
{
"company_id": "0000896262",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2010/feature_distribution/feature_distribution_0000896262.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2010/graphs/IME_0000896262.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000896262.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000896262_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2010/plot_over_time/0000896262_main_keyfigs.svg",
"name": "Amedisys INC",
"rank": 6,
"regression_plot": "No stock price available",
"report_text": "The relative strengths and weaknesses of Amedisys INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Amedisys INC compared to the market average is the variable Other Net Income, increasing the Economic Capital Ratio by 77% points.The greatest weakness of Amedisys INC is the variable Other Expenses, reducing the Economic Capital Ratio by 50% points.
The company's Economic Capital Ratio, given in the ranking table, is 212%, being 22% points above the market average of 191%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2010/report/0000896262_2011_Amedisys_INC.pdf",
"shrinked_graph_json": {
"2009": {
"Liabilities, Current": "3.61",
"Liabilities": "11.3",
"Stockholders Equity": "6.14",
"ECR before LimitedLiability": "8.16",
"Long Term Liabilities": "9.40",
"Other Liabilities": "-1.69",
"Other Expenses": "-60.9",
"Expenses": "-3.17",
"Net Income": "1.31",
"General and Administrative Expense": "11.3",
"Cost of Goods and Services Sold": "57.3",
"Labor Expense": "-21.5",
"Operating Costs and Expenses": "12.9",
"Other Revenues": "-81.2",
"Revenues": "-81.2",
"Intangible Assets": "7.32",
"Assets, Current": "-4.89",
"Property Plant and Equipment": "-1.71",
"Comprehensive Net Income": "1.31",
"Other Net Income": "91.4",
"Economic Capital Ratio": "8.57"
},
"2010": {
"Assets, Current": "-7.22",
"Assets": "-16.2",
"Liabilities": "47.8",
"Stockholders Equity": "-9.62",
"ECR before LimitedLiability": "19.8",
"Property Plant and Equipment": "-12.4",
"Assets, Non-Current": "-2.37",
"Intangible Assets": "7.23",
"Other Liabilities": "11.5",
"Long Term Liabilities": "36.7",
"Other Expenses": "-50.4",
"Expenses": "-31.3",
"Revenues": "-45.4",
"Net Income": "-3.37",
"Cost of Goods and Services Sold": "15.2",
"General and Administrative Expense": "6.96",
"Labor Expense": "-16.3",
"Operating Costs and Expenses": "12.3",
"Other Revenues": "-45.4",
"Other Net Income": "76.5",
"Economic Capital Ratio": "21.7"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2010/plot_over_time/0000896262_strength_weakness.svg",
"table_records": {
"2009": {
"input_variables": {
"Assets, Current": "218,036",
"Assets, Non-Current": "17,865",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "28,312",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "844,531",
"Labor Expense": "327,738",
"Liabilities, Current": "229,306",
"Long Term Liabilities": "177,311",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "1,012,832",
"Other Liabilities": "29,399",
"Other Net Income": "1,505,105",
"Other Revenues": "0",
"Property Plant and Equipment": "91,919",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "1,172,351",
"Liabilities": "436,016",
"Expenses": "1,368,882",
"Revenues": "0",
"Stockholders Equity": "736,335",
"Net Income": "136,223",
"Comprehensive Net Income": "136,223",
"BaseVar": "2,241,177",
"ECR before LimitedLiability": "150%",
"Economic Capital Ratio": "205%"
}
},
"2010": {
"input_variables": {
"Assets, Current": "293,930",
"Assets, Non-Current": "22,536",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "34,589",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "844,805",
"Labor Expense": "357,502",
"Liabilities, Current": "216,304",
"Long Term Liabilities": "151,520",
"Operating Costs and Expenses": "0",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "1,121,027",
"Other Liabilities": "52,286",
"Other Net Income": "1,626,391",
"Other Revenues": "0",
"Property Plant and Equipment": "138,554",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "1,299,825",
"Liabilities": "420,110",
"Expenses": "1,513,118",
"Revenues": "0",
"Stockholders Equity": "879,715",
"Net Income": "113,273",
"Comprehensive Net Income": "113,273",
"BaseVar": "2,429,722",
"ECR before LimitedLiability": "162%",
"Economic Capital Ratio": "212%"
}
}
},
"top_rated": false,
"trend": -4.0,
"value": 2.1231867139461933,
"company_index": "https://www.realrate-archive.com/us_health_services/2010/industry_indexes/0000896262.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2010/analytics/equity/0000896262.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2010/analytics/profit_loss/0000896262.svg"
},
{
"company_id": "0000019411",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2010/feature_distribution/feature_distribution_0000019411.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2010/graphs/IME_0000019411.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000019411.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000019411_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2010/plot_over_time/0000019411_main_keyfigs.svg",
"name": "Magellan Health INC",
"rank": 7,
"regression_plot": "No stock price available",
"report_text": "The relative strengths and weaknesses of Magellan Health INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Magellan Health INC compared to the market average is the variable Other Revenues, increasing the Economic Capital Ratio by 126% points.The greatest weakness of Magellan Health INC is the variable Other Expenses, reducing the Economic Capital Ratio by 148% points.
The company's Economic Capital Ratio, given in the ranking table, is 211%, being 20% points above the market average of 191%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2010/report/0000019411_2011_Magellan_Health_INC.pdf",
"shrinked_graph_json": {
"2010": {
"Assets, Current": "5.49",
"Assets": "-32.3",
"Liabilities": "80.2",
"Stockholders Equity": "-50.4",
"ECR before LimitedLiability": "18.7",
"Property Plant and Equipment": "-19.2",
"Intangible Assets": "-21.2",
"Other Liabilities": "10.5",
"Long Term Liabilities": "74.5",
"Other Expenses": "-148",
"Expenses": "-70.2",
"Revenues": "126",
"Net Income": "-7.40",
"Cost of Goods and Services Sold": "20.5",
"General and Administrative Expense": "9.41",
"Labor Expense": "15.1",
"Operating Costs and Expenses": "16.7",
"Other Revenues": "126",
"Comprehensive Net Income": "-5.66",
"Other Net Income": "-77.3",
"Economic Capital Ratio": "20.5"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2010/plot_over_time/0000019411_strength_weakness.svg",
"table_records": {
"2010": {
"input_variables": {
"Assets, Current": "858,487",
"Assets, Non-Current": "2,396",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "54,682",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "480,936",
"Labor Expense": "0",
"Liabilities, Current": "390,169",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "0",
"Other Assets": "95,799",
"Other Compr. Net Income": "-105",
"Other Expenses": "2,775,899",
"Other Liabilities": "120,248",
"Other Net Income": "0",
"Other Revenues": "2,969,240",
"Property Plant and Equipment": "111,814",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "1,549,432",
"Liabilities": "510,417",
"Expenses": "2,830,581",
"Revenues": "2,969,240",
"Stockholders Equity": "1,039,015",
"Net Income": "138,659",
"Comprehensive Net Income": "138,554",
"BaseVar": "3,929,888",
"ECR before LimitedLiability": "160%",
"Economic Capital Ratio": "211%"
}
}
},
"top_rated": false,
"trend": null,
"value": 2.1115438151843717,
"company_index": "https://www.realrate-archive.com/us_health_services/2010/industry_indexes/0000019411.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2010/analytics/equity/0000019411.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2010/analytics/profit_loss/0000019411.svg"
},
{
"company_id": "0000019584",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2010/feature_distribution/feature_distribution_0000019584.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2010/graphs/IME_0000019584.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000019584.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000019584_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2010/plot_over_time/0000019584_main_keyfigs.svg",
"name": "Chemed CORP",
"rank": 8,
"regression_plot": "No stock price available",
"report_text": "The relative strengths and weaknesses of Chemed CORP are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Chemed CORP compared to the market average is the variable Other Revenues, increasing the Economic Capital Ratio by 102% points.The greatest weakness of Chemed CORP is the variable Cost of Goods and Services Sold, reducing the Economic Capital Ratio by 87% points.
The company's Economic Capital Ratio, given in the ranking table, is 188%, being 2.2% points below the market average of 191%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2010/report/0000019584_2011_Chemed_CORP.pdf",
"shrinked_graph_json": {
"2010": {
"Assets, Current": "-12.0",
"Assets": "-30.2",
"Liabilities": "40.9",
"Stockholders Equity": "-43.3",
"ECR before LimitedLiability": "-3.98",
"Property Plant and Equipment": "-18.7",
"Assets, Non-Current": "-3.86",
"Other Liabilities": "8.86",
"Liabilities, Current": "5.35",
"Long Term Liabilities": "28.3",
"Other Expenses": "32.6",
"Expenses": "-39.6",
"Revenues": "102",
"Net Income": "-4.16",
"Cost of Goods and Services Sold": "-86.6",
"General and Administrative Expense": "-14.7",
"Labor Expense": "12.6",
"Operating Costs and Expenses": "13.9",
"Other Revenues": "102",
"Comprehensive Net Income": "-2.73",
"Other Net Income": "-58.7",
"Economic Capital Ratio": "-2.17"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2010/plot_over_time/0000019584_strength_weakness.svg",
"table_records": {
"2010": {
"input_variables": {
"Assets, Current": "196,797",
"Assets, Non-Current": "11,015",
"Cost of Goods and Services Sold": "906,016",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "201,964",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "514,753",
"Labor Expense": "0",
"Liabilities, Current": "149,342",
"Long Term Liabilities": "165,834",
"Operating Costs and Expenses": "0",
"Other Assets": "28,304",
"Other Compr. Net Income": "0",
"Other Expenses": "93,002",
"Other Liabilities": "52,936",
"Other Net Income": "2,268",
"Other Revenues": "1,280,545",
"Property Plant and Equipment": "79,292",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "830,161",
"Liabilities": "368,112",
"Expenses": "1,200,982",
"Revenues": "1,280,545",
"Stockholders Equity": "462,049",
"Net Income": "81,831",
"Comprehensive Net Income": "81,831",
"BaseVar": "1,841,034",
"ECR before LimitedLiability": "125%",
"Economic Capital Ratio": "188%"
}
}
},
"top_rated": false,
"trend": null,
"value": 1.8849581808648517,
"company_index": "https://www.realrate-archive.com/us_health_services/2010/industry_indexes/0000019584.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2010/analytics/equity/0000019584.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2010/analytics/profit_loss/0000019584.svg"
},
{
"company_id": "0000882235",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2010/feature_distribution/feature_distribution_0000882235.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2010/graphs/IME_0000882235.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000000000.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000000000_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2010/plot_over_time/0000882235_main_keyfigs.svg",
"name": "Lincare Holdings INC",
"rank": 9,
"regression_plot": "No stock price available",
"report_text": "The relative strengths and weaknesses of Lincare Holdings INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Lincare Holdings INC compared to the market average is the variable Other Revenues, increasing the Economic Capital Ratio by 46% points.The greatest weakness of Lincare Holdings INC is the variable Other Liabilities, reducing the Economic Capital Ratio by 81% points.
The company's Economic Capital Ratio, given in the ranking table, is 175%, being 16% points below the market average of 191%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2010/report/0000882235_2011_Lincare_Holdings_INC.pdf",
"shrinked_graph_json": {
"2010": {
"Assets, Current": "-5.56",
"Assets": "-5.76",
"Liabilities": "-8.99",
"Stockholders Equity": "-15.7",
"ECR before LimitedLiability": "-17.9",
"Property Plant and Equipment": "-8.38",
"Assets, Non-Current": "-3.42",
"Intangible Assets": "16.6",
"Other Liabilities": "-80.6",
"Liabilities, Current": "10.3",
"Long Term Liabilities": "41.5",
"Other Revenues": "45.8",
"Revenues": "45.8",
"Operating Costs and Expenses": "-8.51",
"Economic Capital Ratio": "-16.1",
"Other Expenses": "22.5",
"Cost of Goods and Services Sold": "-8.84",
"General and Administrative Expense": "-9.57",
"Labor Expense": "8.59",
"Other Net Income": "-40.2",
"Depreciation, Depletion, Amortization": "-3.72"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2010/plot_over_time/0000882235_strength_weakness.svg",
"table_records": {
"2010": {
"input_variables": {
"Assets, Current": "443,298",
"Assets, Non-Current": "7,690",
"Cost of Goods and Services Sold": "453,905",
"Depreciation, Depletion, Amortization": "116,783",
"General and Administrative Expense": "333,094",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "1,258,065",
"Labor Expense": "0",
"Liabilities, Current": "174,750",
"Long Term Liabilities": "0",
"Operating Costs and Expenses": "399,393",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "148,768",
"Other Liabilities": "875,332",
"Other Net Income": "-35,688",
"Other Revenues": "1,669,205",
"Property Plant and Equipment": "338,778",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "2,047,831",
"Liabilities": "1,050,082",
"Expenses": "1,451,943",
"Revenues": "1,669,205",
"Stockholders Equity": "997,749",
"Net Income": "181,574",
"Comprehensive Net Income": "181,574",
"BaseVar": "3,127,374",
"ECR before LimitedLiability": "105%",
"Economic Capital Ratio": "175%"
}
}
},
"top_rated": false,
"trend": null,
"value": 1.7460544507222573,
"company_index": "https://www.realrate-archive.com/us_health_services/2010/industry_indexes/0000882235.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2010/analytics/equity/0000882235.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2010/analytics/profit_loss/0000882235.svg"
},
{
"company_id": "0001301611",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2010/feature_distribution/feature_distribution_0001301611.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2010/graphs/IME_0001301611.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001301611.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001301611_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2010/plot_over_time/0001301611_main_keyfigs.svg",
"name": "Legacy Lifepoint Health INC",
"rank": 10,
"regression_plot": "No stock price available",
"report_text": "The relative strengths and weaknesses of Legacy Lifepoint Health INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Legacy Lifepoint Health INC compared to the market average is the variable Other Net Income, increasing the Economic Capital Ratio by 35% points.The greatest weakness of Legacy Lifepoint Health INC is the variable Other Revenues, reducing the Economic Capital Ratio by 32% points.
The company's Economic Capital Ratio, given in the ranking table, is 165%, being 26% points below the market average of 191%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2010/report/0001301611_2011_Legacy_Lifepoint_Health_INC.pdf",
"shrinked_graph_json": {
"2010": {
"Assets, Current": "-7.71",
"Assets": "-6.84",
"Liabilities": "-13.4",
"Stockholders Equity": "-19.9",
"ECR before LimitedLiability": "-27.6",
"Property Plant and Equipment": "13.3",
"Intangible Assets": "-5.11",
"Liabilities, Current": "11.6",
"Long Term Liabilities": "-24.7",
"Other Expenses": "4.68",
"Expenses": "-4.10",
"Revenues": "-32.2",
"Net Income": "-5.67",
"Cost of Goods and Services Sold": "12.0",
"General and Administrative Expense": "5.44",
"Labor Expense": "-19.3",
"Operating Costs and Expenses": "-4.06",
"Other Revenues": "-32.2",
"Comprehensive Net Income": "-4.69",
"Other Net Income": "34.7",
"Economic Capital Ratio": "-25.8"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2010/plot_over_time/0001301611_strength_weakness.svg",
"table_records": {
"2010": {
"input_variables": {
"Assets, Current": "823,100",
"Assets, Non-Current": "9,700",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "148,500",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "1,623,800",
"Labor Expense": "1,270,300",
"Liabilities, Current": "324,300",
"Long Term Liabilities": "1,570,500",
"Operating Costs and Expenses": "605,200",
"Other Assets": "27,200",
"Other Compr. Net Income": "0",
"Other Expenses": "1,079,700",
"Other Liabilities": "351,000",
"Other Net Income": "3,262,300",
"Other Revenues": "0",
"Property Plant and Equipment": "1,668,600",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "4,152,400",
"Liabilities": "2,245,800",
"Expenses": "3,103,700",
"Revenues": "0",
"Stockholders Equity": "1,906,600",
"Net Income": "158,600",
"Comprehensive Net Income": "158,600",
"BaseVar": "6,382,100",
"ECR before LimitedLiability": "91%",
"Economic Capital Ratio": "165%"
}
}
},
"top_rated": false,
"trend": null,
"value": 1.6487557317683414,
"company_index": "https://www.realrate-archive.com/us_health_services/2010/industry_indexes/0001301611.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2010/analytics/equity/0001301611.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2010/analytics/profit_loss/0001301611.svg"
},
{
"company_id": "0000920148",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2010/feature_distribution/feature_distribution_0000920148.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2010/graphs/IME_0000920148.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000920148.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000920148_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2010/plot_over_time/0000920148_main_keyfigs.svg",
"name": "Laboratory Corp OF America Holdings",
"rank": 11,
"regression_plot": "No stock price available",
"report_text": "The relative strengths and weaknesses of Laboratory Corp OF America Holdings are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Laboratory Corp OF America Holdings compared to the market average is the variable Other Revenues, increasing the Economic Capital Ratio by 45% points.The greatest weakness of Laboratory Corp OF America Holdings is the variable Other Net Income, reducing the Economic Capital Ratio by 39% points.
The company's Economic Capital Ratio, given in the ranking table, is 160%, being 30% points below the market average of 191%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2010/report/0000920148_2011_Laboratory_Corp_OF_America_Holdings.pdf",
"shrinked_graph_json": {
"2009": {
"Assets": "9.99",
"Stockholders Equity": "-10.7",
"ECR before LimitedLiability": "-28.7",
"Intangible Assets": "11.8",
"Assets, Current": "-3.40",
"Liabilities, Current": "-26.2",
"Liabilities": "-35.2",
"Long Term Liabilities": "-10.7",
"Other Liabilities": "2.65",
"Other Expenses": "13.2",
"Expenses": "15.1",
"Revenues": "25.4",
"Net Income": "2.19",
"General and Administrative Expense": "-8.43",
"Cost of Goods and Services Sold": "-5.80",
"Labor Expense": "4.56",
"Operating Costs and Expenses": "11.0",
"Other Revenues": "25.4",
"Comprehensive Net Income": "2.19",
"Other Net Income": "-34.9",
"Economic Capital Ratio": "-28.3"
},
"2010": {
"Assets, Current": "-9.24",
"Assets": "-8.24",
"Liabilities": "-22.2",
"Stockholders Equity": "-27.7",
"ECR before LimitedLiability": "-32.2",
"Property Plant and Equipment": "-15.0",
"Assets, Non-Current": "-2.71",
"Intangible Assets": "27.6",
"Other Liabilities": "13.1",
"Liabilities, Current": "-23.8",
"Long Term Liabilities": "-12.2",
"Other Revenues": "44.6",
"Revenues": "44.6",
"Operating Costs and Expenses": "9.70",
"Economic Capital Ratio": "-30.4",
"Other Expenses": "23.9",
"Cost of Goods and Services Sold": "-29.9",
"General and Administrative Expense": "-9.80",
"Labor Expense": "8.79",
"Other Net Income": "-39.2",
"Depreciation, Depletion, Amortization": "1.54"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2010/plot_over_time/0000920148_strength_weakness.svg",
"table_records": {
"2009": {
"input_variables": {
"Assets, Current": "935,600",
"Assets, Non-Current": "90,700",
"Cost of Goods and Services Sold": "2,723,800",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "958,900",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "3,239,300",
"Labor Expense": "0",
"Liabilities, Current": "1,596,100",
"Long Term Liabilities": "1,135,600",
"Operating Costs and Expenses": "0",
"Other Assets": "71,400",
"Other Compr. Net Income": "0",
"Other Expenses": "405,100",
"Other Liabilities": "0",
"Other Net Income": "-51,300",
"Other Revenues": "4,694,700",
"Property Plant and Equipment": "500,800",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "4,837,800",
"Liabilities": "2,731,700",
"Expenses": "4,087,800",
"Revenues": "4,694,700",
"Stockholders Equity": "2,106,100",
"Net Income": "555,600",
"Comprehensive Net Income": "555,600",
"BaseVar": "8,201,650",
"ECR before LimitedLiability": "95%",
"Economic Capital Ratio": "168%"
}
},
"2010": {
"input_variables": {
"Assets, Current": "1,143,800",
"Assets, Non-Current": "103,200",
"Cost of Goods and Services Sold": "2,906,100",
"Depreciation, Depletion, Amortization": "0",
"General and Administrative Expense": "1,034,300",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "4,275,400",
"Labor Expense": "0",
"Liabilities, Current": "1,722,800",
"Long Term Liabilities": "1,978,100",
"Operating Costs and Expenses": "0",
"Other Assets": "78,500",
"Other Compr. Net Income": "0",
"Other Expenses": "416,700",
"Other Liabilities": "0",
"Other Net Income": "-51,200",
"Other Revenues": "5,003,900",
"Property Plant and Equipment": "586,900",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "6,187,800",
"Liabilities": "3,700,900",
"Expenses": "4,357,100",
"Revenues": "5,003,900",
"Stockholders Equity": "2,486,900",
"Net Income": "595,600",
"Comprehensive Net Income": "595,600",
"BaseVar": "9,650,450",
"ECR before LimitedLiability": "85%",
"Economic Capital Ratio": "160%"
}
}
},
"top_rated": false,
"trend": -7.0,
"value": 1.602247610379269,
"company_index": "https://www.realrate-archive.com/us_health_services/2010/industry_indexes/0000920148.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2010/analytics/equity/0000920148.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2010/analytics/profit_loss/0000920148.svg"
},
{
"company_id": "0000785161",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2010/feature_distribution/feature_distribution_0000785161.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2010/graphs/IME_0000785161.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000785161.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000785161_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2010/plot_over_time/0000785161_main_keyfigs.svg",
"name": "Encompass Health Corp",
"rank": 12,
"regression_plot": "No stock price available",
"report_text": "The relative strengths and weaknesses of Encompass Health Corp are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Encompass Health Corp compared to the market average is the variable Other Net Income, increasing the Economic Capital Ratio by 36% points.The greatest weakness of Encompass Health Corp is the variable Long Term Liabilities, reducing the Economic Capital Ratio by 65% points.
The company's Economic Capital Ratio, given in the ranking table, is 147%, being 44% points below the market average of 191%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2010/report/0000785161_2011_Encompass_Health_Corp.pdf",
"shrinked_graph_json": {
"2010": {
"Assets, Current": "-10.5",
"Assets": "-8.75",
"Liabilities": "-60.9",
"Stockholders Equity": "-51.3",
"ECR before LimitedLiability": "-45.9",
"Other Assets": "33.0",
"Intangible Assets": "-20.3",
"Other Liabilities": "3.47",
"Long Term Liabilities": "-64.7",
"Other Expenses": "10.6",
"Expenses": "24.6",
"Revenues": "-29.4",
"Net Income": "26.5",
"Cost of Goods and Services Sold": "11.1",
"Labor Expense": "8.14",
"Operating Costs and Expenses": "-5.68",
"Depreciation, Depletion, Amortization": "-1.30",
"Other Revenues": "-29.4",
"Comprehensive Net Income": "25.9",
"Other Net Income": "35.6",
"Economic Capital Ratio": "-44.1"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2010/plot_over_time/0000785161_strength_weakness.svg",
"table_records": {
"2010": {
"input_variables": {
"Assets, Current": "406,200",
"Assets, Non-Current": "90,400",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "76,400",
"General and Administrative Expense": "106,200",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "480,100",
"Labor Expense": "0",
"Liabilities, Current": "359,300",
"Long Term Liabilities": "1,496,800",
"Operating Costs and Expenses": "407,700",
"Other Assets": "710,000",
"Other Compr. Net Income": "-40,300",
"Other Expenses": "457,600",
"Other Liabilities": "130,800",
"Other Net Income": "1,987,700",
"Other Revenues": "0",
"Property Plant and Equipment": "685,400",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "2,372,100",
"Liabilities": "1,986,900",
"Expenses": "1,047,900",
"Revenues": "0",
"Stockholders Equity": "385,200",
"Net Income": "939,800",
"Comprehensive Net Income": "899,500",
"BaseVar": "3,717,450",
"ECR before LimitedLiability": "67%",
"Economic Capital Ratio": "147%"
}
}
},
"top_rated": false,
"trend": null,
"value": 1.4657014591490949,
"company_index": "https://www.realrate-archive.com/us_health_services/2010/industry_indexes/0000785161.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2010/analytics/equity/0000785161.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2010/analytics/profit_loss/0000785161.svg"
},
{
"company_id": "0000927066",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2010/feature_distribution/feature_distribution_0000927066.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2010/graphs/IME_0000927066.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000927066.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000927066_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2010/plot_over_time/0000927066_main_keyfigs.svg",
"name": "Davita INC",
"rank": 13,
"regression_plot": "No stock price available",
"report_text": "The relative strengths and weaknesses of Davita INC are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Davita INC compared to the market average is the variable Other Net Income, increasing the Economic Capital Ratio by 34% points.The greatest weakness of Davita INC is the variable Long Term Liabilities, reducing the Economic Capital Ratio by 48% points.
The company's Economic Capital Ratio, given in the ranking table, is 139%, being 51% points below the market average of 191%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2010/report/0000927066_2011_Davita_INC.pdf",
"shrinked_graph_json": {
"2009": {
"Assets": "17.8",
"Stockholders Equity": "-20.5",
"ECR before LimitedLiability": "-50.7",
"Assets, Current": "9.43",
"Property Plant and Equipment": "6.46",
"Liabilities, Current": "6.74",
"Liabilities": "-56.3",
"Long Term Liabilities": "-57.8",
"Other Liabilities": "-5.71",
"Other Expenses": "12.6",
"Expenses": "20.6",
"Revenues": "-56.5",
"Net Income": "-2.14",
"General and Administrative Expense": "2.71",
"Cost of Goods and Services Sold": "49.5",
"Labor Expense": "4.46",
"Operating Costs and Expenses": "-38.9",
"Other Revenues": "-56.5",
"Comprehensive Net Income": "-2.14",
"Other Net Income": "45.1",
"Economic Capital Ratio": "-50.3"
},
"2010": {
"Assets, Current": "2.37",
"Assets": "-13.2",
"Liabilities": "-36.4",
"Stockholders Equity": "-43.0",
"ECR before LimitedLiability": "-53.1",
"Property Plant and Equipment": "-14.1",
"Assets, Non-Current": "-4.65",
"Intangible Assets": "6.02",
"Other Liabilities": "4.18",
"Liabilities, Current": "6.13",
"Long Term Liabilities": "-48.4",
"Other Revenues": "-33.4",
"Revenues": "-33.4",
"Net Income": "-4.20",
"Other Expenses": "24.1",
"Comprehensive Net Income": "-3.16",
"Cost of Goods and Services Sold": "12.8",
"Labor Expense": "9.39",
"Operating Costs and Expenses": "-38.6",
"Other Net Income": "33.7",
"Economic Capital Ratio": "-51.3"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2010/plot_over_time/0000927066_strength_weakness.svg",
"table_records": {
"2009": {
"input_variables": {
"Assets, Current": "2,302,521",
"Assets, Non-Current": "32,615",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "228,986",
"General and Administrative Expense": "531,531",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "4,087,928",
"Labor Expense": "0",
"Liabilities, Current": "1,046,941",
"Long Term Liabilities": "3,619,909",
"Operating Costs and Expenses": "4,248,668",
"Other Assets": "30,247",
"Other Compr. Net Income": "0",
"Other Expenses": "623,564",
"Other Liabilities": "365,502",
"Other Net Income": "6,108,800",
"Other Revenues": "3,708",
"Property Plant and Equipment": "1,104,925",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "7,558,236",
"Liabilities": "5,032,352",
"Expenses": "5,632,749",
"Revenues": "3,708",
"Stockholders Equity": "2,525,884",
"Net Income": "479,759",
"Comprehensive Net Income": "479,759",
"BaseVar": "12,167,922",
"ECR before LimitedLiability": "66%",
"Economic Capital Ratio": "146%"
}
},
"2010": {
"input_variables": {
"Assets, Current": "2,622,854",
"Assets, Non-Current": "32,054",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "234,378",
"General and Administrative Expense": "579,000",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "4,253,942",
"Labor Expense": "0",
"Liabilities, Current": "924,345",
"Long Term Liabilities": "4,323,140",
"Operating Costs and Expenses": "4,474,735",
"Other Assets": "34,766",
"Other Compr. Net Income": "0",
"Other Expenses": "678,479",
"Other Liabilities": "446,753",
"Other Net Income": "6,447,391",
"Other Revenues": "3,420",
"Property Plant and Equipment": "1,170,808",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "8,114,424",
"Liabilities": "5,694,238",
"Expenses": "5,966,592",
"Revenues": "3,420",
"Stockholders Equity": "2,420,186",
"Net Income": "484,219",
"Comprehensive Net Income": "484,219",
"BaseVar": "13,113,032",
"ECR before LimitedLiability": "58%",
"Economic Capital Ratio": "139%"
}
}
},
"top_rated": false,
"trend": -8.0,
"value": 1.3940815059177551,
"company_index": "https://www.realrate-archive.com/us_health_services/2010/industry_indexes/0000927066.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2010/analytics/equity/0000927066.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2010/analytics/profit_loss/0000927066.svg"
},
{
"company_id": "0001332349",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2010/feature_distribution/feature_distribution_0001332349.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2010/graphs/IME_0001332349.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001332349.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001332349_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2010/plot_over_time/0001332349_main_keyfigs.svg",
"name": "Brookdale Senior Living Inc",
"rank": 14,
"regression_plot": "No stock price available",
"report_text": "The relative strengths and weaknesses of Brookdale Senior Living Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Brookdale Senior Living Inc compared to the market average is the variable Property Plant and Equipment, increasing the Economic Capital Ratio by 47% points.The greatest weakness of Brookdale Senior Living Inc is the variable Liabilities, reducing the Economic Capital Ratio by 61% points.
The company's Economic Capital Ratio, given in the ranking table, is 122%, being 68% points below the market average of 191%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2010/report/0001332349_2011_Brookdale_Senior_Living_Inc.pdf",
"shrinked_graph_json": {
"2010": {
"Liabilities": "-60.8",
"Stockholders Equity": "-40.8",
"ECR before LimitedLiability": "-70.3",
"Long Term Liabilities": "-58.8",
"Other Expenses": "-29.0",
"Expenses": "13.3",
"Revenues": "16.7",
"Net Income": "-9.61",
"Cost of Goods and Services Sold": "11.3",
"General and Administrative Expense": "8.07",
"Labor Expense": "8.30",
"Operating Costs and Expenses": "9.17",
"Depreciation, Depletion, Amortization": "7.93",
"Other Revenues": "16.7",
"Assets, Current": "-19.9",
"Property Plant and Equipment": "47.3",
"Other Assets": "4.64",
"Intangible Assets": "-35.7",
"Comprehensive Net Income": "-8.71",
"Other Net Income": "-35.9",
"Economic Capital Ratio": "-68.5"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2010/plot_over_time/0001332349_strength_weakness.svg",
"table_records": {
"2010": {
"input_variables": {
"Assets, Current": "328,109",
"Assets, Non-Current": "98,973",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "-292,341",
"General and Administrative Expense": "-131,709",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "109,693",
"Labor Expense": "0",
"Liabilities, Current": "606,358",
"Long Term Liabilities": "2,527,885",
"Operating Costs and Expenses": "0",
"Other Assets": "256,853",
"Other Compr. Net Income": "0",
"Other Expenses": "2,681,492",
"Other Liabilities": "336,230",
"Other Net Income": "-4,723",
"Other Revenues": "2,213,264",
"Property Plant and Equipment": "3,736,842",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "4,530,470",
"Liabilities": "3,470,473",
"Expenses": "2,257,442",
"Revenues": "2,213,264",
"Stockholders Equity": "1,059,997",
"Net Income": "-48,901",
"Comprehensive Net Income": "-48,901",
"BaseVar": "6,238,186",
"ECR before LimitedLiability": "37%",
"Economic Capital Ratio": "122%"
}
}
},
"top_rated": false,
"trend": null,
"value": 1.221650115701142,
"company_index": "https://www.realrate-archive.com/us_health_services/2010/industry_indexes/0001332349.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2010/analytics/equity/0001332349.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2010/analytics/profit_loss/0001332349.svg"
},
{
"company_id": "0001108109",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2010/feature_distribution/feature_distribution_0001108109.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2010/graphs/IME_0001108109.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0001108109.svg",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0001108109_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2010/plot_over_time/0001108109_main_keyfigs.svg",
"name": "Community Health System Inc",
"rank": 15,
"regression_plot": "No stock price available",
"report_text": "The relative strengths and weaknesses of Community Health System Inc are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Community Health System Inc compared to the market average is the variable Other Net Income, increasing the Economic Capital Ratio by 30% points.The greatest weakness of Community Health System Inc is the variable Long Term Liabilities, reducing the Economic Capital Ratio by 65% points.
The company's Economic Capital Ratio, given in the ranking table, is 117%, being 74% points below the market average of 191%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2010/report/0001108109_2011_Community_Health_System_Inc.pdf",
"shrinked_graph_json": {
"2010": {
"Assets, Current": "-15.7",
"Assets": "-26.4",
"Liabilities": "-46.3",
"Stockholders Equity": "-65.0",
"ECR before LimitedLiability": "-75.6",
"Property Plant and Equipment": "17.0",
"Intangible Assets": "-24.9",
"Other Liabilities": "7.40",
"Liabilities, Current": "8.63",
"Long Term Liabilities": "-65.4",
"Other Expenses": "5.75",
"Expenses": "-4.46",
"Revenues": "-37.7",
"Net Income": "-8.79",
"Cost of Goods and Services Sold": "14.6",
"General and Administrative Expense": "6.62",
"Labor Expense": "-23.1",
"Other Revenues": "-37.7",
"Comprehensive Net Income": "-7.62",
"Other Net Income": "29.6",
"Economic Capital Ratio": "-73.8"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2010/plot_over_time/0001108109_strength_weakness.svg",
"table_records": {
"2010": {
"input_variables": {
"Assets, Current": "2,871,193",
"Assets, Non-Current": "1,169,559",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "609,839",
"General and Administrative Expense": "0",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "4,199,905",
"Labor Expense": "5,237,971",
"Liabilities, Current": "1,642,040",
"Long Term Liabilities": "9,810,057",
"Operating Costs and Expenses": "2,406,596",
"Other Assets": "0",
"Other Compr. Net Income": "0",
"Other Expenses": "4,429,085",
"Other Liabilities": "608,177",
"Other Net Income": "13,031,932",
"Other Revenues": "0",
"Property Plant and Equipment": "6,457,466",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "14,698,123",
"Liabilities": "12,060,274",
"Expenses": "12,683,491",
"Revenues": "0",
"Stockholders Equity": "2,637,849",
"Net Income": "348,441",
"Comprehensive Net Income": "348,441",
"BaseVar": "26,236,910",
"ECR before LimitedLiability": "31%",
"Economic Capital Ratio": "117%"
}
}
},
"top_rated": false,
"trend": null,
"value": 1.1688902031184654,
"company_index": "https://www.realrate-archive.com/us_health_services/2010/industry_indexes/0001108109.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2010/analytics/equity/0001108109.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2010/analytics/profit_loss/0001108109.svg"
},
{
"company_id": "0001001604",
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2010/feature_distribution/feature_distribution_0001001604.svg",
"graph_url": "https://www.realrate-archive.com/us_health_services/2010/graphs/IME_0001001604.svg",
"logo_url": "https://www.realrate-archive.com/us_health_services/logos/0000000000.png",
"logo_url_256x256": "https://www.realrate-archive.com/us_health_services/logos/0000000000_256x256.png",
"main_keyfigs_over_time_plot": "https://www.realrate-archive.com/us_health_services/2010/plot_over_time/0001001604_main_keyfigs.svg",
"name": "Emeritus CORP WA",
"rank": 16,
"regression_plot": "No stock price available",
"report_text": "The relative strengths and weaknesses of Emeritus CORP WA are analyzed with respect to the market average, including all of its competitors. We analyzed all variables having an effect on the Economic Capital Ratio.
The greatest strength of Emeritus CORP WA compared to the market average is the variable Property Plant and Equipment, increasing the Economic Capital Ratio by 37% points.The greatest weakness of Emeritus CORP WA is the variable Liabilities, reducing the Economic Capital Ratio by 79% points.
The company's Economic Capital Ratio, given in the ranking table, is 105%, being 85% points below the market average of 191%.",
"report_url": "https://www.realrate-archive.com/us_health_services/2010/report/0001001604_2011_Emeritus_CORP_WA.pdf",
"shrinked_graph_json": {
"2010": {
"Assets, Current": "-19.8",
"Assets": "9.69",
"Liabilities": "-79.4",
"Stockholders Equity": "-51.0",
"ECR before LimitedLiability": "-87.1",
"Property Plant and Equipment": "36.5",
"Other Assets": "4.37",
"Intangible Assets": "-37.6",
"Other Liabilities": "-33.9",
"Liabilities, Current": "5.36",
"Long Term Liabilities": "-47.1",
"Expenses": "18.0",
"Revenues": "7.32",
"Net Income": "-10.6",
"Cost of Goods and Services Sold": "11.1",
"Labor Expense": "8.14",
"Operating Costs and Expenses": "8.98",
"Other Revenues": "7.32",
"Comprehensive Net Income": "-9.69",
"Other Net Income": "-39.1",
"Economic Capital Ratio": "-85.3"
}
},
"strength_weakness_over_time_plot": "https://www.realrate-archive.com/us_health_services/2010/plot_over_time/0001001604_strength_weakness.svg",
"table_records": {
"2010": {
"input_variables": {
"Assets, Current": "216,649",
"Assets, Non-Current": "23,969",
"Cost of Goods and Services Sold": "0",
"Depreciation, Depletion, Amortization": "86,697",
"General and Administrative Expense": "74,480",
"Goodwill Impairment Loss": "0",
"Intangible Assets": "75,820",
"Labor Expense": "0",
"Liabilities, Current": "234,377",
"Long Term Liabilities": "1,305,757",
"Operating Costs and Expenses": "0",
"Other Assets": "133,798",
"Other Compr. Net Income": "0",
"Other Expenses": "786,855",
"Other Liabilities": "722,152",
"Other Net Income": "-116,875",
"Other Revenues": "1,007,065",
"Property Plant and Equipment": "2,163,556",
"Research And Development Expense": "0",
"Selling and Marketing Expense": "0"
},
"output_variables": {
"Assets": "2,613,792",
"Liabilities": "2,262,286",
"Expenses": "948,032",
"Revenues": "1,007,065",
"Stockholders Equity": "351,506",
"Net Income": "-57,842",
"Comprehensive Net Income": "-57,842",
"BaseVar": "3,474,025",
"ECR before LimitedLiability": "19%",
"Economic Capital Ratio": "105%"
}
}
},
"top_rated": false,
"trend": null,
"value": 1.0535950408202408,
"company_index": "https://www.realrate-archive.com/us_health_services/2010/industry_indexes/0001001604.svg",
"analysing_equity": "https://www.realrate-archive.com/us_health_services/2010/analytics/equity/0001001604.svg",
"analysing_profit_loss": "https://www.realrate-archive.com/us_health_services/2010/analytics/profit_loss/0001001604.svg"
}
],
"feature_distribution_plot": "https://www.realrate-archive.com/us_health_services/2010/feature_distribution/feature_distribution.svg",
"final_var_label": "Economic Capital Ratio",
"industry_box": [
[
"Revenues",
"21.5 B"
],
[
"Assets",
"67.9 B"
],
[
"Expenses",
"50.9 B"
],
[
"Stockholders Equity",
"31.4 B"
]
],
"industry_id": "us_health_services",
"industry_label": "Health Services",
"num_companies": 16,
"num_top_companies": 4,
"ecr_records": {
"2009": {
"0001022079": {
"rank": 1,
"ecr": "268"
},
"0000896262": {
"rank": 2,
"ecr": "205"
},
"0001014739": {
"rank": 3,
"ecr": "194"
},
"0000920148": {
"rank": 4,
"ecr": "168"
},
"0000927066": {
"rank": 5,
"ecr": "146"
}
},
"2010": {
"0000895930": {
"rank": 1,
"ecr": "295"
},
"0000352915": {
"rank": 2,
"ecr": "266"
},
"0000731012": {
"rank": 3,
"ecr": "265"
},
"0001022079": {
"rank": 4,
"ecr": "261"
},
"0000893949": {
"rank": 5,
"ecr": "221"
},
"0000896262": {
"rank": 6,
"ecr": "212"
},
"0000019411": {
"rank": 7,
"ecr": "211"
},
"0000019584": {
"rank": 8,
"ecr": "188"
},
"0000882235": {
"rank": 9,
"ecr": "175"
},
"0001301611": {
"rank": 10,
"ecr": "165"
},
"0000920148": {
"rank": 11,
"ecr": "160"
},
"0000785161": {
"rank": 12,
"ecr": "147"
},
"0000927066": {
"rank": 13,
"ecr": "139"
},
"0001332349": {
"rank": 14,
"ecr": "122"
},
"0001108109": {
"rank": 15,
"ecr": "117"
},
"0001001604": {
"rank": 16,
"ecr": "105"
}
}
},
"rating_box": [
[
"Top rated",
"4 of 16"
],
[
"Best, worst rating",
"295 %, 105 %"
],
[
"New companies",
"12"
]
],
"regression_plot": null,
"scentences": [
"Quest Diagnostics INC climbed -3 positions from 1 to 4 due to its excellent Liabilities.",
"Davita INC lost 8 positions from 5 to 13 due to its bad Long Term Liabilities.",
"Amsurg CORP entered the 2011 ranking at rank 1, making it the best newcomer.",
"The biggest company by assets, Community Health System Inc, is only ranked at place 15 whereas the smallest company, Healthcare Services Group Inc, is financially stronger at rank 3."
],
"url_segment": "2011-us-health-services",
"year": 2011,
"feature_importance": "https://www.realrate-archive.com/us_health_services/2010/feature_importance/feature_importance.svg",
"obs_ecr": {
"0000920148": {
"2011": {
"obs_EconomicCapitalRatio": 1.663923414286983
},
"2012": {
"obs_EconomicCapitalRatio": 1.4407170672094647
},
"2013": {
"obs_EconomicCapitalRatio": 1.323792718489346
},
"2014": {
"obs_EconomicCapitalRatio": 1.470242712096841
},
"2015": {
"obs_EconomicCapitalRatio": 1.0214010482206495
},
"2016": {
"obs_EconomicCapitalRatio": 1.0954224043543792
},
"2017": {
"obs_EconomicCapitalRatio": 1.1879221981344004
},
"2018": {
"obs_EconomicCapitalRatio": 0.9477895219666614
},
"2019": {
"obs_EconomicCapitalRatio": 1.0949627880974482
},
"2021": {
"obs_EconomicCapitalRatio": 1.8399468745460335
},
"2022": {
"obs_EconomicCapitalRatio": 1.3068086669177197
},
"2023": {
"obs_EconomicCapitalRatio": 1.4492522183616858
},
"2024": {
"obs_EconomicCapitalRatio": 1.3176610991160915
},
"2025": {
"obs_EconomicCapitalRatio": 1.487123295160136
}
},
"0001022079": {
"2011": {
"obs_EconomicCapitalRatio": 1.267911138352765
},
"2012": {
"obs_EconomicCapitalRatio": 1.3862017229025643
},
"2013": {
"obs_EconomicCapitalRatio": 1.2031665213960887
},
"2014": {
"obs_EconomicCapitalRatio": 1.3396669994127473
},
"2015": {
"obs_EconomicCapitalRatio": 1.4903768348790714
},
"2016": {
"obs_EconomicCapitalRatio": 1.9095314518428617
},
"2017": {
"obs_EconomicCapitalRatio": 1.9713217210734026
},
"2018": {
"obs_EconomicCapitalRatio": 1.542844211769263
},
"2019": {
"obs_EconomicCapitalRatio": 1.7072037694942166
},
"2020": {
"obs_EconomicCapitalRatio": 1.8434784506594455
},
"2021": {
"obs_EconomicCapitalRatio": 2.4801222638557205
},
"2022": {
"obs_EconomicCapitalRatio": 2.303864240107965
},
"2023": {
"obs_EconomicCapitalRatio": 1.846925205369018
},
"2024": {
"obs_EconomicCapitalRatio": 1.810747224018149
},
"2025": {
"obs_EconomicCapitalRatio": 2.0966621477837926
}
},
"0001014739": {
"2011": {
"obs_EconomicCapitalRatio": 0.5455058467503717
},
"2018": {
"obs_EconomicCapitalRatio": 0.754424645512964
},
"2019": {
"obs_EconomicCapitalRatio": 1.1945159127889264
},
"2020": {
"obs_EconomicCapitalRatio": 1.3372488526870943
},
"2021": {
"obs_EconomicCapitalRatio": 2.287045484201052
},
"2022": {
"obs_EconomicCapitalRatio": 2.2629706450273175
},
"2023": {
"obs_EconomicCapitalRatio": 2.369798550093667
},
"2024": {
"obs_EconomicCapitalRatio": 1.431722453146353
},
"2025": {
"obs_EconomicCapitalRatio": 1.840512605157507
}
},
"0000927066": {
"2011": {
"obs_EconomicCapitalRatio": 0.9398495018958859
},
"2012": {
"obs_EconomicCapitalRatio": 0.7666044539176664
},
"2013": {
"obs_EconomicCapitalRatio": 0.9312599987060045
},
"2014": {
"obs_EconomicCapitalRatio": 1.0994201795059793
},
"2015": {
"obs_EconomicCapitalRatio": 0.9688014559679293
},
"2016": {
"obs_EconomicCapitalRatio": 0.8477409793726618
},
"2017": {
"obs_EconomicCapitalRatio": 0.824189439126132
},
"2018": {
"obs_EconomicCapitalRatio": 0.5103927085716712
},
"2019": {
"obs_EconomicCapitalRatio": 0.6180542558126978
},
"2020": {
"obs_EconomicCapitalRatio": 0.8322454933184945
},
"2021": {
"obs_EconomicCapitalRatio": 0.7116567354875124
},
"2022": {
"obs_EconomicCapitalRatio": 0.41763359468294975
},
"2023": {
"obs_EconomicCapitalRatio": 0.6154642053257157
},
"2024": {
"obs_EconomicCapitalRatio": 0.7615486641660242
},
"2025": {
"obs_EconomicCapitalRatio": 0.4785719594527293
}
},
"0000731012": {
"2011": {
"obs_EconomicCapitalRatio": 5.269267575857689
},
"2012": {
"obs_EconomicCapitalRatio": 5.962718744523781
},
"2013": {
"obs_EconomicCapitalRatio": 5.857390336910617
},
"2014": {
"obs_EconomicCapitalRatio": 6.010654031230302
},
"2015": {
"obs_EconomicCapitalRatio": 7.220294551700417
},
"2016": {
"obs_EconomicCapitalRatio": 7.592293402247349
},
"2017": {
"obs_EconomicCapitalRatio": 7.648779377528277
},
"2018": {
"obs_EconomicCapitalRatio": 5.948743829553438
},
"2019": {
"obs_EconomicCapitalRatio": 3.6760348928352986
},
"2020": {
"obs_EconomicCapitalRatio": 3.9099437641971453
},
"2021": {
"obs_EconomicCapitalRatio": 2.5108136581327076
},
"2022": {
"obs_EconomicCapitalRatio": 2.0121273406342404
},
"2023": {
"obs_EconomicCapitalRatio": 1.503981335283937
},
"2024": {
"obs_EconomicCapitalRatio": 1.6965676535663106
},
"2025": {
"obs_EconomicCapitalRatio": 2.8638609322827606
}
},
"0001332349": {
"2011": {
"obs_EconomicCapitalRatio": 0.5097293760371813
},
"2012": {
"obs_EconomicCapitalRatio": 0.7321295047182582
},
"2013": {
"obs_EconomicCapitalRatio": 0.7994065409175654
},
"2014": {
"obs_EconomicCapitalRatio": 0.7310943113449674
},
"2015": {
"obs_EconomicCapitalRatio": 0.3861457207385632
},
"2016": {
"obs_EconomicCapitalRatio": 0.29096091336542823
},
"2017": {
"obs_EconomicCapitalRatio": 0.26366034864469273
},
"2018": {
"obs_EconomicCapitalRatio": 0.21789711902103157
},
"2019": {
"obs_EconomicCapitalRatio": 0.1903375612099341
},
"2020": {
"obs_EconomicCapitalRatio": 0.12286042900676535
},
"2021": {
"obs_EconomicCapitalRatio": 0.15643986114831185
},
"2022": {
"obs_EconomicCapitalRatio": 0.09034196093382922
},
"2023": {
"obs_EconomicCapitalRatio": 0.20082534077007566
},
"2024": {
"obs_EconomicCapitalRatio": 0.16215618529739215
},
"2025": {
"obs_EconomicCapitalRatio": 0.42924858957859935
}
},
"0000785161": {
"2011": {
"obs_EconomicCapitalRatio": 0.6799239972910698
},
"2020": {
"obs_EconomicCapitalRatio": 1.4182305505026696
},
"2021": {
"obs_EconomicCapitalRatio": 1.0814619308963784
},
"2022": {
"obs_EconomicCapitalRatio": 1.2168672567310501
},
"2023": {
"obs_EconomicCapitalRatio": 1.3276977177956595
},
"2024": {
"obs_EconomicCapitalRatio": 1.8380528311696858
},
"2025": {
"obs_EconomicCapitalRatio": 1.9742320708117875
}
},
"0000893949": {
"2011": {
"obs_EconomicCapitalRatio": 2.4472442147004276
},
"2012": {
"obs_EconomicCapitalRatio": 2.324430027116807
},
"2013": {
"obs_EconomicCapitalRatio": 1.4153980642767163
},
"2014": {
"obs_EconomicCapitalRatio": 2.705255141805469
},
"2015": {
"obs_EconomicCapitalRatio": 2.0403070361793634
},
"2016": {
"obs_EconomicCapitalRatio": 1.5757900099368114
},
"2017": {
"obs_EconomicCapitalRatio": 1.1407480403624084
},
"2018": {
"obs_EconomicCapitalRatio": 0.6705050146055793
},
"2020": {
"obs_EconomicCapitalRatio": 0.6921913773195393
},
"2021": {
"obs_EconomicCapitalRatio": 1.0300015663795175
},
"2022": {
"obs_EconomicCapitalRatio": 0.6489855323488252
}
},
"0000352915": {
"2011": {
"obs_EconomicCapitalRatio": 0.0553602404895168
},
"2012": {
"obs_EconomicCapitalRatio": 0.0667388364815138
},
"2013": {
"obs_EconomicCapitalRatio": 0.10746186223320742
},
"2014": {
"obs_EconomicCapitalRatio": 0.1377020365266119
},
"2015": {
"obs_EconomicCapitalRatio": 0.14053215356654963
},
"2016": {
"obs_EconomicCapitalRatio": 0.11621934942230021
},
"2017": {
"obs_EconomicCapitalRatio": 0.114780744950106
},
"2018": {
"obs_EconomicCapitalRatio": 0.11647085422878821
},
"2019": {
"obs_EconomicCapitalRatio": 0.13844490306808155
},
"2020": {
"obs_EconomicCapitalRatio": 0.10967403520573908
},
"2021": {
"obs_EconomicCapitalRatio": 0.10964465033831926
},
"2022": {
"obs_EconomicCapitalRatio": 0.11838136871728291
}
},
"0001108109": {
"2011": {
"obs_EconomicCapitalRatio": 0.11115589636411495
},
"2018": {
"obs_EconomicCapitalRatio": 0.020711060055743875
},
"2019": {
"obs_EconomicCapitalRatio": 0.02087391002128378
},
"2020": {
"obs_EconomicCapitalRatio": 0.055024335706864366
},
"2021": {
"obs_EconomicCapitalRatio": 0.11238728706954826
},
"2022": {
"obs_EconomicCapitalRatio": 0.03480717712086575
}
},
"0000019584": {
"2011": {
"obs_EconomicCapitalRatio": 1.6007792741509022
},
"2012": {
"obs_EconomicCapitalRatio": 1.9490756925806219
},
"2013": {
"obs_EconomicCapitalRatio": 1.914488847567999
},
"2014": {
"obs_EconomicCapitalRatio": 2.7276355806390216
},
"2015": {
"obs_EconomicCapitalRatio": 4.108866362531992
},
"2016": {
"obs_EconomicCapitalRatio": 4.056449959720801
},
"2017": {
"obs_EconomicCapitalRatio": 5.771321991229426
},
"2018": {
"obs_EconomicCapitalRatio": 6.4038316847246515
},
"2019": {
"obs_EconomicCapitalRatio": 7.58709219872699
},
"2020": {
"obs_EconomicCapitalRatio": 8.473284302050429
},
"2021": {
"obs_EconomicCapitalRatio": 7.75419875738273
},
"2022": {
"obs_EconomicCapitalRatio": 7.217090228251971
},
"2023": {
"obs_EconomicCapitalRatio": 7.848784782008866
},
"2024": {
"obs_EconomicCapitalRatio": 7.020418240239263
},
"2025": {
"obs_EconomicCapitalRatio": 5.834267895037539
}
},
"0000885978": {
"2011": {
"obs_EconomicCapitalRatio": 1.8249280503248755
},
"2012": {
"obs_EconomicCapitalRatio": 2.5724402670747026
},
"2013": {
"obs_EconomicCapitalRatio": 2.440280256916831
},
"2014": {
"obs_EconomicCapitalRatio": 2.7841283878931624
},
"2015": {
"obs_EconomicCapitalRatio": 3.1734064882953517
},
"2016": {
"obs_EconomicCapitalRatio": 3.0246117738545863
},
"2017": {
"obs_EconomicCapitalRatio": 3.0139939481056994
},
"2018": {
"obs_EconomicCapitalRatio": 4.338573763941583
},
"2019": {
"obs_EconomicCapitalRatio": 3.5619391851687783
},
"2020": {
"obs_EconomicCapitalRatio": 3.608060136945878
},
"2021": {
"obs_EconomicCapitalRatio": 2.2035870209619968
},
"2022": {
"obs_EconomicCapitalRatio": 1.6051840413020122
},
"2023": {
"obs_EconomicCapitalRatio": 1.9917917705186083
}
},
"0001043000": {
"2011": {
"obs_EconomicCapitalRatio": 0.8293232149926116
},
"2012": {
"obs_EconomicCapitalRatio": 1.4742528917925262
},
"2013": {
"obs_EconomicCapitalRatio": 1.7089349147012525
},
"2014": {
"obs_EconomicCapitalRatio": 1.4658517655187218
},
"2015": {
"obs_EconomicCapitalRatio": 1.1163300237064913
},
"2016": {
"obs_EconomicCapitalRatio": 0.8011463796423269
},
"2017": {
"obs_EconomicCapitalRatio": 0.6657619630661099
},
"2018": {
"obs_EconomicCapitalRatio": 0.3499332196919161
},
"2019": {
"obs_EconomicCapitalRatio": 0.1435327336460731
},
"2020": {
"obs_EconomicCapitalRatio": 0.7691184527453718
},
"2021": {
"obs_EconomicCapitalRatio": 0.2472761050128782
},
"2022": {
"obs_EconomicCapitalRatio": 0.11342826064079066
},
"2023": {
"obs_EconomicCapitalRatio": 0.12215537075834612
},
"2024": {
"obs_EconomicCapitalRatio": 0.5680879390824175
},
"2025": {
"obs_EconomicCapitalRatio": 0.7440503530902668
}
},
"0001047335": {
"2011": {
"obs_EconomicCapitalRatio": 0.7030648064303432
},
"2012": {
"obs_EconomicCapitalRatio": 0.7986366131163368
},
"2013": {
"obs_EconomicCapitalRatio": 0.8810375321554819
},
"2014": {
"obs_EconomicCapitalRatio": 1.0391703058215966
},
"2015": {
"obs_EconomicCapitalRatio": 1.1792883497574127
},
"2016": {
"obs_EconomicCapitalRatio": 1.4494970214093919
},
"2018": {
"obs_EconomicCapitalRatio": 1.3317026977764668
},
"2019": {
"obs_EconomicCapitalRatio": 1.2199733107599542
},
"2020": {
"obs_EconomicCapitalRatio": 0.9159128240235758
},
"2021": {
"obs_EconomicCapitalRatio": 0.974181561146432
},
"2022": {
"obs_EconomicCapitalRatio": 1.0185115295379144
},
"2023": {
"obs_EconomicCapitalRatio": 1.6164670839378312
},
"2024": {
"obs_EconomicCapitalRatio": 1.6149386864581519
},
"2025": {
"obs_EconomicCapitalRatio": 2.1616166738307125
}
},
"0001125376": {
"2011": {
"obs_EconomicCapitalRatio": 1399.2430658223911
},
"2013": {
"obs_EconomicCapitalRatio": 1.5989526445598863
},
"2014": {
"obs_EconomicCapitalRatio": 2.650540849834678
},
"2015": {
"obs_EconomicCapitalRatio": 1.0482953396008179
},
"2016": {
"obs_EconomicCapitalRatio": 1.43190595552074
},
"2017": {
"obs_EconomicCapitalRatio": 1.298859391390505
},
"2018": {
"obs_EconomicCapitalRatio": 2.258510853301959
},
"2020": {
"obs_EconomicCapitalRatio": 1.8301794320010123
},
"2021": {
"obs_EconomicCapitalRatio": 1.9403448034625244
},
"2022": {
"obs_EconomicCapitalRatio": 1.8563425494032437
},
"2023": {
"obs_EconomicCapitalRatio": 1.8496058389879095
},
"2024": {
"obs_EconomicCapitalRatio": 2.05284060578683
},
"2025": {
"obs_EconomicCapitalRatio": 2.3535867345733354
}
},
"0001320414": {
"2011": {
"obs_EconomicCapitalRatio": 0.4096752742860925
},
"2012": {
"obs_EconomicCapitalRatio": 0.4783822969318578
},
"2019": {
"obs_EconomicCapitalRatio": 0.44294593397271526
},
"2020": {
"obs_EconomicCapitalRatio": 0.4886895190465231
},
"2021": {
"obs_EconomicCapitalRatio": 0.5402804679327372
},
"2022": {
"obs_EconomicCapitalRatio": 0.4248829592184213
},
"2023": {
"obs_EconomicCapitalRatio": 0.42798358473497655
},
"2024": {
"obs_EconomicCapitalRatio": 0.5226074625086464
},
"2025": {
"obs_EconomicCapitalRatio": 0.37980794355505854
}
},
"0000860730": {
"2011": {
"obs_EconomicCapitalRatio": 0.4286902706847537
},
"2012": {
"obs_EconomicCapitalRatio": 0.7436572689093711
},
"2013": {
"obs_EconomicCapitalRatio": 1.1206263058489003
},
"2014": {
"obs_EconomicCapitalRatio": 1.6352993886568388
},
"2015": {
"obs_EconomicCapitalRatio": 1.3417604658415376
},
"2016": {
"obs_EconomicCapitalRatio": 1.2987056545778823
},
"2017": {
"obs_EconomicCapitalRatio": 1.3588133779185207
},
"2018": {
"obs_EconomicCapitalRatio": 1.690582150801402
},
"2019": {
"obs_EconomicCapitalRatio": 1.8037161509724668
},
"2020": {
"obs_EconomicCapitalRatio": 1.8890537469679993
},
"2021": {
"obs_EconomicCapitalRatio": 2.5241883533491696
},
"2022": {
"obs_EconomicCapitalRatio": 2.1212350019474413
}
},
"0000744825": {
"2011": {
"obs_EconomicCapitalRatio": 0.3013270885313684
},
"2012": {
"obs_EconomicCapitalRatio": 0.2786524695351668
},
"2014": {
"obs_EconomicCapitalRatio": 0.32061093649804834
},
"2015": {
"obs_EconomicCapitalRatio": 0.27328011615268516
},
"2016": {
"obs_EconomicCapitalRatio": 0.507485494797134
},
"2019": {
"obs_EconomicCapitalRatio": 0.47749793539701463
},
"2020": {
"obs_EconomicCapitalRatio": 0.4205109400804776
},
"2021": {
"obs_EconomicCapitalRatio": 0.5408241989221371
},
"2022": {
"obs_EconomicCapitalRatio": 0.551218384744222
},
"2023": {
"obs_EconomicCapitalRatio": 0.43442074411285875
},
"2024": {
"obs_EconomicCapitalRatio": 0.4546792591572024
},
"2025": {
"obs_EconomicCapitalRatio": 0.33160145828748444
}
},
"0001124140": {
"2011": {
"obs_EconomicCapitalRatio": 8.166711011815341
},
"2012": {
"obs_EconomicCapitalRatio": 10.92431895435195
},
"2013": {
"obs_EconomicCapitalRatio": 11.153573080374903
},
"2014": {
"obs_EconomicCapitalRatio": 13.87272928515707
},
"2015": {
"obs_EconomicCapitalRatio": 4.498727547879557
},
"2016": {
"obs_EconomicCapitalRatio": 7.186191888088503
},
"2017": {
"obs_EconomicCapitalRatio": 18.744201313894912
},
"2018": {
"obs_EconomicCapitalRatio": 6.328551540717717
},
"2019": {
"obs_EconomicCapitalRatio": 5.219972902769483
},
"2020": {
"obs_EconomicCapitalRatio": 5.8461764979525555
},
"2021": {
"obs_EconomicCapitalRatio": 2.693158098121996
},
"2022": {
"obs_EconomicCapitalRatio": 1.8966263786723718
},
"2023": {
"obs_EconomicCapitalRatio": 2.675453724118233
},
"2024": {
"obs_EconomicCapitalRatio": 2.2518786178746426
},
"2025": {
"obs_EconomicCapitalRatio": 4.130870838625185
}
},
"0001416876": {
"2011": {
"obs_EconomicCapitalRatio": 6.005379679717644
}
},
"0001468328": {
"2011": {
"obs_EconomicCapitalRatio": 0.3339618789772089
},
"2012": {
"obs_EconomicCapitalRatio": 0.7361666670249098
},
"2013": {
"obs_EconomicCapitalRatio": 2.4221362236697006
},
"2014": {
"obs_EconomicCapitalRatio": 2.247833539524948
},
"2015": {
"obs_EconomicCapitalRatio": 2.1765194287839145
},
"2016": {
"obs_EconomicCapitalRatio": 2.669870396751533
},
"2017": {
"obs_EconomicCapitalRatio": 2.225023618015959
},
"2018": {
"obs_EconomicCapitalRatio": 3.999238099074307
},
"2019": {
"obs_EconomicCapitalRatio": 3.6416558946940984
},
"2020": {
"obs_EconomicCapitalRatio": 2.8759264575125654
},
"2021": {
"obs_EconomicCapitalRatio": 2.2511133868811335
},
"2022": {
"obs_EconomicCapitalRatio": 2.6282063462550895
},
"2025": {
"obs_EconomicCapitalRatio": 2.289809915160802
}
},
"0000320017": {
"2011": {
"obs_EconomicCapitalRatio": 0.7845651461442082
},
"2017": {
"obs_EconomicCapitalRatio": 0.8441397867838771
},
"2018": {
"obs_EconomicCapitalRatio": 1.450029837906473
},
"2019": {
"obs_EconomicCapitalRatio": 1.3779837923295708
},
"2020": {
"obs_EconomicCapitalRatio": 1.4413081267952197
},
"2021": {
"obs_EconomicCapitalRatio": 1.0188229702380915
},
"2022": {
"obs_EconomicCapitalRatio": 0.4977353007777521
},
"2023": {
"obs_EconomicCapitalRatio": 0.7478434592910281
},
"2024": {
"obs_EconomicCapitalRatio": 1.2214669648900207
},
"2025": {
"obs_EconomicCapitalRatio": 1.697675419723171
}
},
"0000862692": {
"2012": {
"obs_EconomicCapitalRatio": 1.6030934401757337
},
"2013": {
"obs_EconomicCapitalRatio": 1.4904801656352977
},
"2014": {
"obs_EconomicCapitalRatio": 2.29460235161725
},
"2015": {
"obs_EconomicCapitalRatio": 1.5555905563042072
},
"2016": {
"obs_EconomicCapitalRatio": 0.8703509764233575
},
"2017": {
"obs_EconomicCapitalRatio": 1.745275561455659
},
"2018": {
"obs_EconomicCapitalRatio": 1.0071098975322699
},
"2019": {
"obs_EconomicCapitalRatio": 0.9780748861936736
},
"2020": {
"obs_EconomicCapitalRatio": 0.9549593957112342
},
"2021": {
"obs_EconomicCapitalRatio": 1.392951720347594
},
"2022": {
"obs_EconomicCapitalRatio": 0.49974368258860846
}
},
"0001138476": {
"2011": {
"obs_EconomicCapitalRatio": 1.0159968197446956
},
"2012": {
"obs_EconomicCapitalRatio": 2.6993579909368757
},
"2013": {
"obs_EconomicCapitalRatio": 13.336168649980072
},
"2014": {
"obs_EconomicCapitalRatio": 9.494406793998118
},
"2015": {
"obs_EconomicCapitalRatio": 1.9380748685240585
},
"2016": {
"obs_EconomicCapitalRatio": 2.7272575024723023
},
"2017": {
"obs_EconomicCapitalRatio": 3.028696524958903
},
"2018": {
"obs_EconomicCapitalRatio": 2.885688962134937
},
"2020": {
"obs_EconomicCapitalRatio": 1.8494446405798506
},
"2021": {
"obs_EconomicCapitalRatio": 1.8473038660504764
},
"2022": {
"obs_EconomicCapitalRatio": 1.3523816738275818
},
"2023": {
"obs_EconomicCapitalRatio": 1.4350490259676654
}
},
"0001520697": {
"2011": {
"obs_EconomicCapitalRatio": 0.6081713564397228
},
"2012": {
"obs_EconomicCapitalRatio": 1.2349126249303797
},
"2013": {
"obs_EconomicCapitalRatio": 2.431136189781226
},
"2014": {
"obs_EconomicCapitalRatio": 2.1113051231339535
},
"2015": {
"obs_EconomicCapitalRatio": 1.3038377293511394
},
"2017": {
"obs_EconomicCapitalRatio": 0.5522060999716568
},
"2018": {
"obs_EconomicCapitalRatio": 0.4571543250579229
},
"2019": {
"obs_EconomicCapitalRatio": 0.5212458993293995
},
"2020": {
"obs_EconomicCapitalRatio": 0.7890311768704694
},
"2021": {
"obs_EconomicCapitalRatio": 1.5307713118327542
},
"2022": {
"obs_EconomicCapitalRatio": 2.1315460187424224
}
},
"0000790526": {
"2012": {
"obs_EconomicCapitalRatio": 0.13358036301597942
},
"2013": {
"obs_EconomicCapitalRatio": 0.09085026990368239
},
"2014": {
"obs_EconomicCapitalRatio": 0.5431310806294178
},
"2015": {
"obs_EconomicCapitalRatio": 0.3505983920433856
},
"2016": {
"obs_EconomicCapitalRatio": 0.3682069337967622
},
"2017": {
"obs_EconomicCapitalRatio": 0.5710188707297758
},
"2024": {
"obs_EconomicCapitalRatio": 1.973558336079889
},
"2025": {
"obs_EconomicCapitalRatio": 1.822716365763516
}
},
"0000806517": {
"2012": {
"obs_EconomicCapitalRatio": 4.60715791025414
},
"2014": {
"obs_EconomicCapitalRatio": 3.3264549819016556
},
"2015": {
"obs_EconomicCapitalRatio": 2.6996817675995533
},
"2016": {
"obs_EconomicCapitalRatio": 5.952072258353605
},
"2017": {
"obs_EconomicCapitalRatio": 5.394572797693456
},
"2018": {
"obs_EconomicCapitalRatio": 4.474632330961844
},
"2019": {
"obs_EconomicCapitalRatio": 2.3961219464673005
},
"2020": {
"obs_EconomicCapitalRatio": 1.3262727318756238
},
"2021": {
"obs_EconomicCapitalRatio": 2.3750491230099042
},
"2022": {
"obs_EconomicCapitalRatio": 2.026772375492911
},
"2023": {
"obs_EconomicCapitalRatio": 1.8485765440798285
},
"2024": {
"obs_EconomicCapitalRatio": 1.9825798798980514
}
},
"0001505497": {
"2012": {
"obs_EconomicCapitalRatio": 0.0
},
"2013": {
"obs_EconomicCapitalRatio": 0.0
},
"2014": {
"obs_EconomicCapitalRatio": 0.0
},
"2015": {
"obs_EconomicCapitalRatio": 0.0
},
"2016": {
"obs_EconomicCapitalRatio": 0.0
},
"2017": {
"obs_EconomicCapitalRatio": 0.0
},
"2018": {
"obs_EconomicCapitalRatio": 0.0
},
"2021": {
"obs_EconomicCapitalRatio": 1.3561386622109721
},
"2022": {
"obs_EconomicCapitalRatio": 1.2272159903361468
},
"2024": {
"obs_EconomicCapitalRatio": 1.3211056224972826
},
"2025": {
"obs_EconomicCapitalRatio": 2.6392582155377524
}
},
"0001089815": {
"2012": {
"obs_EconomicCapitalRatio": 0.27461324171750273
},
"2013": {
"obs_EconomicCapitalRatio": 0.5652182034205951
},
"2014": {
"obs_EconomicCapitalRatio": 0.5784619345201361
},
"2015": {
"obs_EconomicCapitalRatio": 0.1633049803157926
},
"2016": {
"obs_EconomicCapitalRatio": 0.2753162215937384
},
"2017": {
"obs_EconomicCapitalRatio": 0.4022421591008146
},
"2018": {
"obs_EconomicCapitalRatio": 0.3316176238371148
},
"2019": {
"obs_EconomicCapitalRatio": 0.4783975439001473
},
"2020": {
"obs_EconomicCapitalRatio": 0.919678507057958
},
"2021": {
"obs_EconomicCapitalRatio": 0.9237462870829648
},
"2022": {
"obs_EconomicCapitalRatio": 1.539192368372456
},
"2023": {
"obs_EconomicCapitalRatio": 3.7939396247631856
},
"2024": {
"obs_EconomicCapitalRatio": 6.231155648407009
},
"2025": {
"obs_EconomicCapitalRatio": 7.171877525786021
}
},
"0000802257": {
"2013": {
"obs_EconomicCapitalRatio": 0.0
},
"2014": {
"obs_EconomicCapitalRatio": 0.0
},
"2015": {
"obs_EconomicCapitalRatio": 0.0
},
"2020": {
"obs_EconomicCapitalRatio": 1.9744005113966216
},
"2021": {
"obs_EconomicCapitalRatio": 3.6904748791510964
},
"2022": {
"obs_EconomicCapitalRatio": 18.356104790380286
}
},
"0000948320": {
"2013": {
"obs_EconomicCapitalRatio": 19.122408312536397
},
"2014": {
"obs_EconomicCapitalRatio": 12.544382169245214
},
"2015": {
"obs_EconomicCapitalRatio": 10.709507411111359
},
"2018": {
"obs_EconomicCapitalRatio": 3.298409579098017
},
"2019": {
"obs_EconomicCapitalRatio": 1.7309580285301396
},
"2020": {
"obs_EconomicCapitalRatio": 10.40786666630324
},
"2021": {
"obs_EconomicCapitalRatio": 3.3516170514357024
},
"2022": {
"obs_EconomicCapitalRatio": 2.1668311020786786
},
"2023": {
"obs_EconomicCapitalRatio": 5.666378657404718
},
"2024": {
"obs_EconomicCapitalRatio": 2.9540486786201483
},
"2025": {
"obs_EconomicCapitalRatio": 2.8022594173750055
}
},
"0001384101": {
"2013": {
"obs_EconomicCapitalRatio": 5.726396731332951
},
"2014": {
"obs_EconomicCapitalRatio": 4.2258505750915285
},
"2015": {
"obs_EconomicCapitalRatio": 4.002792419943674
},
"2016": {
"obs_EconomicCapitalRatio": 2.907069930522243
},
"2017": {
"obs_EconomicCapitalRatio": 3.6955164524484863
},
"2018": {
"obs_EconomicCapitalRatio": 5.903084432595021
},
"2019": {
"obs_EconomicCapitalRatio": 9.17221087672525
},
"2020": {
"obs_EconomicCapitalRatio": 12.009349418296129
},
"2021": {
"obs_EconomicCapitalRatio": 4.569266085280168
},
"2022": {
"obs_EconomicCapitalRatio": 2.957324756862987
},
"2023": {
"obs_EconomicCapitalRatio": 3.476700938886737
},
"2024": {
"obs_EconomicCapitalRatio": 4.4085578126382945
},
"2025": {
"obs_EconomicCapitalRatio": 4.485792425264168
}
},
"0001443863": {
"2013": {
"obs_EconomicCapitalRatio": 3.48321910388931
},
"2014": {
"obs_EconomicCapitalRatio": 3.4046294626511577
},
"2015": {
"obs_EconomicCapitalRatio": 1.5631269234101999
},
"2016": {
"obs_EconomicCapitalRatio": 1.1237533540614515
},
"2018": {
"obs_EconomicCapitalRatio": 4.838143851132696
},
"2020": {
"obs_EconomicCapitalRatio": 1.516717809911702
},
"2021": {
"obs_EconomicCapitalRatio": 6.736268258202685
},
"2022": {
"obs_EconomicCapitalRatio": 1.547614374795819
},
"2025": {
"obs_EconomicCapitalRatio": 0.9131965951472314
}
},
"0001597892": {
"2016": {
"obs_EconomicCapitalRatio": 0.4573910404286819
},
"2017": {
"obs_EconomicCapitalRatio": 0.7307048923124139
},
"2018": {
"obs_EconomicCapitalRatio": 1.0765984359761611
},
"2019": {
"obs_EconomicCapitalRatio": 2.9112556811490666
},
"2020": {
"obs_EconomicCapitalRatio": 0.0805492763350369
},
"2023": {
"obs_EconomicCapitalRatio": 2.308586009655766
}
},
"0001217234": {
"2014": {
"obs_EconomicCapitalRatio": 2.106099248600515
},
"2015": {
"obs_EconomicCapitalRatio": 1.8606992876041615
},
"2016": {
"obs_EconomicCapitalRatio": 0.8991741565472338
},
"2017": {
"obs_EconomicCapitalRatio": 2.3625185935969757
},
"2018": {
"obs_EconomicCapitalRatio": 10.988768401944188
},
"2019": {
"obs_EconomicCapitalRatio": 9.295696048608347
},
"2020": {
"obs_EconomicCapitalRatio": 15.894232884028792
},
"2021": {
"obs_EconomicCapitalRatio": 7.107376945609629
},
"2022": {
"obs_EconomicCapitalRatio": 1.868289639503857
},
"2023": {
"obs_EconomicCapitalRatio": 1.9021864798831671
},
"2024": {
"obs_EconomicCapitalRatio": 3.75555356135359
},
"2025": {
"obs_EconomicCapitalRatio": 3.8258403033619546
}
},
"0000811222": {
"2015": {
"obs_EconomicCapitalRatio": 0.0
},
"2016": {
"obs_EconomicCapitalRatio": 0.0
},
"2017": {
"obs_EconomicCapitalRatio": 0.0
},
"2018": {
"obs_EconomicCapitalRatio": 0.0
},
"2022": {
"obs_EconomicCapitalRatio": 0.0
},
"2023": {
"obs_EconomicCapitalRatio": 0.0
},
"2024": {
"obs_EconomicCapitalRatio": 2.313895027277619
},
"2025": {
"obs_EconomicCapitalRatio": 1.2879555622882315
}
},
"0001477449": {
"2015": {
"obs_EconomicCapitalRatio": 5.544764703239246
},
"2016": {
"obs_EconomicCapitalRatio": 4.7132034470335
},
"2017": {
"obs_EconomicCapitalRatio": 4.690116935020641
},
"2018": {
"obs_EconomicCapitalRatio": 4.243448916525309
},
"2019": {
"obs_EconomicCapitalRatio": 7.066330202032505
},
"2020": {
"obs_EconomicCapitalRatio": 3.2033660875692913
},
"2021": {
"obs_EconomicCapitalRatio": 1.6724116401293925
},
"2022": {
"obs_EconomicCapitalRatio": 1.6400447522007024
},
"2023": {
"obs_EconomicCapitalRatio": 1.4808360827926537
},
"2024": {
"obs_EconomicCapitalRatio": 0.5824872091940608
},
"2025": {
"obs_EconomicCapitalRatio": 0.5880410245147577
}
},
"0001638833": {
"2015": {
"obs_EconomicCapitalRatio": 0.8690576081521365
},
"2016": {
"obs_EconomicCapitalRatio": 0.5809479181547815
},
"2018": {
"obs_EconomicCapitalRatio": 0.19992190836322066
},
"2019": {
"obs_EconomicCapitalRatio": 0.28413337094038393
},
"2020": {
"obs_EconomicCapitalRatio": 0.47610580888076925
},
"2021": {
"obs_EconomicCapitalRatio": 1.3205930250979123
},
"2022": {
"obs_EconomicCapitalRatio": 0.6666538559780858
},
"2023": {
"obs_EconomicCapitalRatio": 1.1049807370417983
},
"2024": {
"obs_EconomicCapitalRatio": 0.6276252284290024
},
"2025": {
"obs_EconomicCapitalRatio": 0.46493861746268283
}
},
"0001590750": {
"2015": {
"obs_EconomicCapitalRatio": 0.932903006677119
},
"2016": {
"obs_EconomicCapitalRatio": 13.0711249565521
},
"2017": {
"obs_EconomicCapitalRatio": 6.356633171990735
},
"2018": {
"obs_EconomicCapitalRatio": 2.0254040755220735
},
"2019": {
"obs_EconomicCapitalRatio": 0.6907471032007421
},
"2020": {
"obs_EconomicCapitalRatio": 14.802536994480796
},
"2021": {
"obs_EconomicCapitalRatio": 4.033972483760562
},
"2023": {
"obs_EconomicCapitalRatio": 4.295100066488977
},
"2024": {
"obs_EconomicCapitalRatio": 3.7757140806874343
},
"2025": {
"obs_EconomicCapitalRatio": 5.655591493377748
}
},
"0001604821": {
"2015": {
"obs_EconomicCapitalRatio": 3.240855334715597
},
"2016": {
"obs_EconomicCapitalRatio": 3.9343020841567653
},
"2017": {
"obs_EconomicCapitalRatio": 2.797164141426769
},
"2018": {
"obs_EconomicCapitalRatio": 3.2298690908277656
},
"2019": {
"obs_EconomicCapitalRatio": 5.987358295647832
},
"2020": {
"obs_EconomicCapitalRatio": 12.840764363166384
},
"2021": {
"obs_EconomicCapitalRatio": 9.697207220674155
},
"2022": {
"obs_EconomicCapitalRatio": 3.8690619189941047
},
"2023": {
"obs_EconomicCapitalRatio": 6.871334386701791
},
"2024": {
"obs_EconomicCapitalRatio": 19.864753055012294
}
},
"0000792935": {
"2016": {
"obs_EconomicCapitalRatio": 0.47107162549473863
},
"2019": {
"obs_EconomicCapitalRatio": 0.06465501080251583
},
"2020": {
"obs_EconomicCapitalRatio": 0.5290719268064846
},
"2021": {
"obs_EconomicCapitalRatio": 0.2676343291130003
},
"2022": {
"obs_EconomicCapitalRatio": 0.13585432723348395
},
"2024": {
"obs_EconomicCapitalRatio": 0.2432404069211452
}
},
"0001674930": {
"2016": {
"obs_EconomicCapitalRatio": 5.977117435291776
},
"2017": {
"obs_EconomicCapitalRatio": 2.4695749151172817
},
"2018": {
"obs_EconomicCapitalRatio": 2.079409314730264
},
"2019": {
"obs_EconomicCapitalRatio": 5.306880144073147
},
"2020": {
"obs_EconomicCapitalRatio": 2.8216283049254067
},
"2021": {
"obs_EconomicCapitalRatio": 4.339147344390559
},
"2022": {
"obs_EconomicCapitalRatio": 1.1938018387890712
}
},
"0001680139": {
"2017": {
"obs_EconomicCapitalRatio": 3.9395693520833825
},
"2018": {
"obs_EconomicCapitalRatio": 6.2256973384254515
},
"2019": {
"obs_EconomicCapitalRatio": 3.533160492046391
},
"2021": {
"obs_EconomicCapitalRatio": 15.437613384223065
},
"2022": {
"obs_EconomicCapitalRatio": 3.5079397431580226
},
"2023": {
"obs_EconomicCapitalRatio": 4.4482071080504575
}
},
"0001603454": {
"2018": {
"obs_EconomicCapitalRatio": 17.66433991837258
},
"2019": {
"obs_EconomicCapitalRatio": 9.527163233702987
},
"2021": {
"obs_EconomicCapitalRatio": 3.7696196477965644
},
"2022": {
"obs_EconomicCapitalRatio": 1.8690407255909658
},
"2023": {
"obs_EconomicCapitalRatio": 2.9173109469879184
},
"2024": {
"obs_EconomicCapitalRatio": 2.485696746340044
},
"2025": {
"obs_EconomicCapitalRatio": 11.243231230995297
}
},
"0001713210": {
"2023": {
"obs_EconomicCapitalRatio": 14.39400262713444
},
"2024": {
"obs_EconomicCapitalRatio": 2.0773963940030575
},
"2025": {
"obs_EconomicCapitalRatio": 0.44125322995284166
}
},
"0000070318": {
"2018": {
"obs_EconomicCapitalRatio": 0.08552924410432898
},
"2019": {
"obs_EconomicCapitalRatio": 0.17754638364786196
},
"2020": {
"obs_EconomicCapitalRatio": 0.16463973728908057
},
"2021": {
"obs_EconomicCapitalRatio": 0.33521955077878823
},
"2022": {
"obs_EconomicCapitalRatio": 0.20317691382837733
},
"2023": {
"obs_EconomicCapitalRatio": 0.30062697803053423
},
"2024": {
"obs_EconomicCapitalRatio": 0.4934054549593957
},
"2025": {
"obs_EconomicCapitalRatio": 0.6933671309524378
}
},
"0001576280": {
"2018": {
"obs_EconomicCapitalRatio": 9.409998338204176
},
"2019": {
"obs_EconomicCapitalRatio": 14.015133034824808
},
"2020": {
"obs_EconomicCapitalRatio": 8.033623509502428
},
"2021": {
"obs_EconomicCapitalRatio": 5.378829839582666
},
"2022": {
"obs_EconomicCapitalRatio": 1.8770406090353164
},
"2023": {
"obs_EconomicCapitalRatio": 1.9270482881595639
},
"2024": {
"obs_EconomicCapitalRatio": 2.4823202710500136
},
"2025": {
"obs_EconomicCapitalRatio": 6.1920599604917745
}
},
"0001766400": {
"2019": {
"obs_EconomicCapitalRatio": 2.2358107646248047
},
"2020": {
"obs_EconomicCapitalRatio": 3.7377872544961175
},
"2021": {
"obs_EconomicCapitalRatio": 1.317407127445334
},
"2022": {
"obs_EconomicCapitalRatio": 0.7196383548705427
},
"2023": {
"obs_EconomicCapitalRatio": 0.8927955560969081
},
"2024": {
"obs_EconomicCapitalRatio": 1.7720749372810554
},
"2025": {
"obs_EconomicCapitalRatio": 1.2970657367956044
}
},
"0001274737": {
"2019": {
"obs_EconomicCapitalRatio": 5.3105465475101905
},
"2020": {
"obs_EconomicCapitalRatio": 2.660107841280965
},
"2021": {
"obs_EconomicCapitalRatio": 2.2167256957939694
},
"2022": {
"obs_EconomicCapitalRatio": 0.6076712499435017
},
"2023": {
"obs_EconomicCapitalRatio": 0.654214032721451
},
"2024": {
"obs_EconomicCapitalRatio": 2.2025057987368397
},
"2025": {
"obs_EconomicCapitalRatio": 2.875555288576213
}
},
"0001447362": {
"2019": {
"obs_EconomicCapitalRatio": 6.498753866445175
},
"2020": {
"obs_EconomicCapitalRatio": 6.026288703848502
},
"2021": {
"obs_EconomicCapitalRatio": 4.175460360278498
},
"2022": {
"obs_EconomicCapitalRatio": 2.4739768633055252
},
"2023": {
"obs_EconomicCapitalRatio": 2.256072832055694
},
"2024": {
"obs_EconomicCapitalRatio": 2.501859695117348
},
"2025": {
"obs_EconomicCapitalRatio": 3.3619067449345166
}
},
"0001527753": {
"2019": {
"obs_EconomicCapitalRatio": 2.953743430117927
},
"2020": {
"obs_EconomicCapitalRatio": 10.527770127762217
},
"2021": {
"obs_EconomicCapitalRatio": 2.645722439374889
},
"2022": {
"obs_EconomicCapitalRatio": 0.47315593157114144
}
},
"0001725255": {
"2019": {
"obs_EconomicCapitalRatio": 0.5857155046057619
},
"2020": {
"obs_EconomicCapitalRatio": 1.4955681062795707
},
"2021": {
"obs_EconomicCapitalRatio": 0.7234441813573314
},
"2022": {
"obs_EconomicCapitalRatio": 0.6234341278934857
},
"2023": {
"obs_EconomicCapitalRatio": 0.26119597375409453
},
"2024": {
"obs_EconomicCapitalRatio": 0.35440894588014293
},
"2025": {
"obs_EconomicCapitalRatio": 0.3887325800588612
}
},
"0001551306": {
"2019": {
"obs_EconomicCapitalRatio": 23.128888643767834
},
"2020": {
"obs_EconomicCapitalRatio": 21.25263485685163
},
"2021": {
"obs_EconomicCapitalRatio": 19.928211362808444
},
"2022": {
"obs_EconomicCapitalRatio": 8.182587418805609
},
"2023": {
"obs_EconomicCapitalRatio": 7.48169024244033
},
"2024": {
"obs_EconomicCapitalRatio": 3.143226224073416
},
"2025": {
"obs_EconomicCapitalRatio": 4.595221185166977
}
},
"0001729149": {
"2019": {
"obs_EconomicCapitalRatio": 3.9141912518645925
},
"2020": {
"obs_EconomicCapitalRatio": 4.377758147257698
},
"2021": {
"obs_EconomicCapitalRatio": 3.1175442632229804
},
"2022": {
"obs_EconomicCapitalRatio": 4.165808200790573
},
"2023": {
"obs_EconomicCapitalRatio": 3.0905943820113806
},
"2024": {
"obs_EconomicCapitalRatio": 2.8280699797927302
},
"2025": {
"obs_EconomicCapitalRatio": 2.208374174708051
}
},
"0001729944": {
"2019": {
"obs_EconomicCapitalRatio": 0.80033022263604
},
"2020": {
"obs_EconomicCapitalRatio": 0.8939501524991209
},
"2021": {
"obs_EconomicCapitalRatio": 1.670257709676602
},
"2022": {
"obs_EconomicCapitalRatio": 0.7555010825436428
},
"2023": {
"obs_EconomicCapitalRatio": 1.486124730980496
},
"2024": {
"obs_EconomicCapitalRatio": 0.5100288861637816
}
},
"0001799191": {
"2020": {
"obs_EconomicCapitalRatio": 1.9354663360497144
},
"2021": {
"obs_EconomicCapitalRatio": 1.4314265160413502
},
"2022": {
"obs_EconomicCapitalRatio": 0.5369289711729511
},
"2024": {
"obs_EconomicCapitalRatio": 0.09570735084291766
},
"2025": {
"obs_EconomicCapitalRatio": 2.001660729797598
}
},
"0001439725": {
"2020": {
"obs_EconomicCapitalRatio": 4.899553478061839
},
"2021": {
"obs_EconomicCapitalRatio": 1.7991006973357486
},
"2022": {
"obs_EconomicCapitalRatio": 0.9045190531820879
}
},
"0001737523": {
"2021": {
"obs_EconomicCapitalRatio": 671.1968392005622
},
"2022": {
"obs_EconomicCapitalRatio": 385.49382888758356
},
"2023": {
"obs_EconomicCapitalRatio": 1.5191647865482536
},
"2024": {
"obs_EconomicCapitalRatio": 0.7490768181400523
},
"2025": {
"obs_EconomicCapitalRatio": 2.0065585272756072
}
},
"0001759655": {
"2021": {
"obs_EconomicCapitalRatio": 5.9854315421959114
},
"2022": {
"obs_EconomicCapitalRatio": 4.9874077872328435
},
"2023": {
"obs_EconomicCapitalRatio": 3.9996069884808416
},
"2024": {
"obs_EconomicCapitalRatio": 3.0209663872592287
},
"2025": {
"obs_EconomicCapitalRatio": 3.0134479613948315
}
},
"0001803901": {
"2021": {
"obs_EconomicCapitalRatio": 2.3239919326101237
},
"2022": {
"obs_EconomicCapitalRatio": 1.1649813946676386
}
},
"0001818331": {
"2021": {
"obs_EconomicCapitalRatio": 3.031702783280354
},
"2022": {
"obs_EconomicCapitalRatio": 0.2650382635460216
},
"2023": {
"obs_EconomicCapitalRatio": 0.2340008975350877
},
"2024": {
"obs_EconomicCapitalRatio": 7.1433325795924105
},
"2025": {
"obs_EconomicCapitalRatio": 10.607580330133818
}
},
"0001822359": {
"2021": {
"obs_EconomicCapitalRatio": 4.529492069938443
},
"2022": {
"obs_EconomicCapitalRatio": 2.771063189488642
},
"2023": {
"obs_EconomicCapitalRatio": 1.6728383727412641
},
"2024": {
"obs_EconomicCapitalRatio": 1.4843694887626384
},
"2025": {
"obs_EconomicCapitalRatio": 0.5634025375829321
}
},
"0001834376": {
"2021": {
"obs_EconomicCapitalRatio": 1.9802948402224156
},
"2022": {
"obs_EconomicCapitalRatio": 2.439532779220166
},
"2023": {
"obs_EconomicCapitalRatio": 1.8744085157804056
},
"2024": {
"obs_EconomicCapitalRatio": 1.3621909662118414
}
},
"0001773751": {
"2021": {
"obs_EconomicCapitalRatio": 4.971853684184344
},
"2022": {
"obs_EconomicCapitalRatio": 6.128488895753875
},
"2023": {
"obs_EconomicCapitalRatio": 6.554674754785222
},
"2024": {
"obs_EconomicCapitalRatio": 12.126553207078992
},
"2025": {
"obs_EconomicCapitalRatio": 4.04039885819204
}
},
"0001870940": {
"2021": {
"obs_EconomicCapitalRatio": 5.033081838177257
},
"2022": {
"obs_EconomicCapitalRatio": 1.132782907988652
},
"2023": {
"obs_EconomicCapitalRatio": 2.5947989753230587
},
"2024": {
"obs_EconomicCapitalRatio": 1.8671046483783382
}
},
"0001534969": {
"2021": {
"obs_EconomicCapitalRatio": 2.8842820361801325
},
"2022": {
"obs_EconomicCapitalRatio": 0.5713512984391965
},
"2023": {
"obs_EconomicCapitalRatio": 3.1922358214415856
}
},
"0001822479": {
"2021": {
"obs_EconomicCapitalRatio": 2.6314647506130555
},
"2022": {
"obs_EconomicCapitalRatio": 0.7794445581652086
},
"2023": {
"obs_EconomicCapitalRatio": 1.6169003077959527
},
"2024": {
"obs_EconomicCapitalRatio": 1.317382776714733
},
"2025": {
"obs_EconomicCapitalRatio": 1.6819107661299355
}
},
"0001831097": {
"2021": {
"obs_EconomicCapitalRatio": 10.135987542140258
},
"2022": {
"obs_EconomicCapitalRatio": 5.716884020987739
},
"2023": {
"obs_EconomicCapitalRatio": 3.6117017245510086
},
"2024": {
"obs_EconomicCapitalRatio": 0.5237840028274809
},
"2025": {
"obs_EconomicCapitalRatio": 0.2429987445135107
}
},
"0001844392": {
"2021": {
"obs_EconomicCapitalRatio": 3.102693963604072
},
"2022": {
"obs_EconomicCapitalRatio": 0.36018627065159414
},
"2024": {
"obs_EconomicCapitalRatio": 0.5451364493905979
},
"2025": {
"obs_EconomicCapitalRatio": 0.3728897696807099
}
},
"0001832511": {
"2022": {
"obs_EconomicCapitalRatio": 0.14225887468579412
},
"2023": {
"obs_EconomicCapitalRatio": 0.21200771759380008
},
"2024": {
"obs_EconomicCapitalRatio": 0.045389475358619244
}
},
"0001892316": {
"2023": {
"obs_EconomicCapitalRatio": 110.39054612853406
},
"2024": {
"obs_EconomicCapitalRatio": 94.60058336986788
}
},
"0001635077": {
"2022": {
"obs_EconomicCapitalRatio": 0.0
},
"2023": {
"obs_EconomicCapitalRatio": 0.0
},
"2024": {
"obs_EconomicCapitalRatio": 0.0
},
"2025": {
"obs_EconomicCapitalRatio": 0.5450667778424255
}
},
"0001803737": {
"2022": {
"obs_EconomicCapitalRatio": 0.5721263204730309
},
"2023": {
"obs_EconomicCapitalRatio": 0.4928465005438502
},
"2024": {
"obs_EconomicCapitalRatio": 0.4077090775440418
},
"2025": {
"obs_EconomicCapitalRatio": 0.5377770193692863
}
},
"0001826667": {
"2023": {
"obs_EconomicCapitalRatio": 5.747039577983446
},
"2024": {
"obs_EconomicCapitalRatio": 3.6673040258093965
},
"2025": {
"obs_EconomicCapitalRatio": 6.744892845411586
}
},
"0001965040": {
"2023": {
"obs_EconomicCapitalRatio": 0.8853775922144298
},
"2024": {
"obs_EconomicCapitalRatio": 0.5806666737511045
},
"2025": {
"obs_EconomicCapitalRatio": 0.6601762335313033
}
},
"0001938046": {
"2023": {
"obs_EconomicCapitalRatio": 7.485743735641145
},
"2024": {
"obs_EconomicCapitalRatio": 0.7342890394360521
},
"2025": {
"obs_EconomicCapitalRatio": 1.2366752765702367
}
},
"0001699031": {
"2024": {
"obs_EconomicCapitalRatio": 0.36247445601460876
},
"2025": {
"obs_EconomicCapitalRatio": 2.141226559604184
}
},
"0001960262": {
"2024": {
"obs_EconomicCapitalRatio": 20.758484759101325
}
}
}
}